| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | retinoic acid binding | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 5.54e-13 | 28 | 157 | 9 | GO:0001972 |
| GeneOntologyMolecularFunction | glucuronosyltransferase activity | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 5.40e-12 | 35 | 157 | 9 | GO:0015020 |
| GeneOntologyMolecularFunction | retinoid binding | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.18e-10 | 48 | 157 | 9 | GO:0005501 |
| GeneOntologyMolecularFunction | isoprenoid binding | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.43e-10 | 49 | 157 | 9 | GO:0019840 |
| GeneOntologyMolecularFunction | monocarboxylic acid binding | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 PC | 1.24e-08 | 107 | 157 | 10 | GO:0033293 |
| GeneOntologyMolecularFunction | organic acid binding | UBR1 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 GRM7 RYR2 UGT1A4 UGT1A1 UGT1A3 PC | 1.12e-07 | 254 | 157 | 13 | GO:0043177 |
| GeneOntologyMolecularFunction | carboxylic acid binding | UBR1 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 GRM7 UGT1A4 UGT1A1 UGT1A3 PC | 4.32e-07 | 239 | 157 | 12 | GO:0031406 |
| GeneOntologyMolecularFunction | glycosyltransferase activity | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 PARP2 UGT1A9 UGT1A4 UGT1A1 UGT1A3 PARP1 PARP4 AGL | 4.75e-07 | 288 | 157 | 13 | GO:0016757 |
| GeneOntologyMolecularFunction | UDP-glycosyltransferase activity | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 3.47e-06 | 153 | 157 | 9 | GO:0008194 |
| GeneOntologyMolecularFunction | hexosyltransferase activity | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 AGL | 6.81e-06 | 211 | 157 | 10 | GO:0016758 |
| GeneOntologyMolecularFunction | NAD+-protein-serine ADP-ribosyltransferase activity | 6.14e-05 | 2 | 157 | 2 | GO:0140805 | |
| GeneOntologyMolecularFunction | protein kinase C binding | 1.71e-04 | 66 | 157 | 5 | GO:0005080 | |
| GeneOntologyMolecularFunction | NAD DNA ADP-ribosyltransferase activity | 1.83e-04 | 3 | 157 | 2 | GO:0140294 | |
| GeneOntologyMolecularFunction | protein homodimerization activity | SPR UGT1A10 UGT1A8 UGT1A7 UGT1A6 SMCHD1 UGT1A5 UGT1A9 MSH2 CBS UGT1A4 UGT1A1 UGT1A3 PARP1 TENM4 KMT2A ALPG | 2.39e-04 | 815 | 157 | 17 | GO:0042803 |
| GeneOntologyMolecularFunction | fatty acid amide hydrolase activity | 3.65e-04 | 4 | 157 | 2 | GO:0017064 | |
| GeneOntologyMolecularFunction | NAD+-protein-glutamate ADP-ribosyltransferase activity | 3.65e-04 | 4 | 157 | 2 | GO:0140807 | |
| GeneOntologyMolecularFunction | histone H3K4 methyltransferase activity | 4.93e-04 | 20 | 157 | 3 | GO:0042800 | |
| GeneOntologyMolecularFunction | NAD+-protein-aspartate ADP-ribosyltransferase activity | 6.05e-04 | 5 | 157 | 2 | GO:0140806 | |
| GeneOntologyMolecularFunction | selenocysteine insertion sequence binding | 9.03e-04 | 6 | 157 | 2 | GO:0035368 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | ABCC1 MYH13 MYO1A MYO6 KIF26A VPS4A ZGRF1 SMCHD1 RNF213 MSH2 DNAH17 AFG3L2 HELLS | 1.15e-03 | 614 | 157 | 13 | GO:0140657 |
| GeneOntologyMolecularFunction | protein heterodimerization activity | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 TENM4 | 1.23e-03 | 398 | 157 | 10 | GO:0046982 |
| GeneOntologyMolecularFunction | modification-dependent protein binding | 1.24e-03 | 206 | 157 | 7 | GO:0140030 | |
| GeneOntologyMolecularFunction | lysophosphatidic acid phosphatase activity | 1.26e-03 | 7 | 157 | 2 | GO:0052642 | |
| GeneOntologyMolecularFunction | NAD+-protein poly-ADP-ribosyltransferase activity | 1.35e-03 | 28 | 157 | 3 | GO:0003950 | |
| GeneOntologyMolecularFunction | NAD+-protein ADP-ribosyltransferase activity | 1.66e-03 | 30 | 157 | 3 | GO:1990404 | |
| GeneOntologyMolecularFunction | histone H3K4 monomethyltransferase activity | 1.67e-03 | 8 | 157 | 2 | GO:0140945 | |
| GeneOntologyMolecularFunction | fatty acid binding | 2.14e-03 | 69 | 157 | 4 | GO:0005504 | |
| GeneOntologyMolecularFunction | actin filament binding | 2.16e-03 | 227 | 157 | 7 | GO:0051015 | |
| GeneOntologyBiologicalProcess | cellular glucuronidation | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.74e-14 | 21 | 156 | 9 | GO:0052695 |
| GeneOntologyBiologicalProcess | glucuronate metabolic process | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.80e-13 | 26 | 156 | 9 | GO:0019585 |
| GeneOntologyBiologicalProcess | uronic acid metabolic process | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.80e-13 | 26 | 156 | 9 | GO:0006063 |
| GeneOntologyBiologicalProcess | flavonoid glucuronidation | 2.32e-11 | 5 | 156 | 5 | GO:0052696 | |
| GeneOntologyBiologicalProcess | flavone metabolic process | 1.38e-10 | 6 | 156 | 5 | GO:0051552 | |
| GeneOntologyBiologicalProcess | flavonoid metabolic process | 2.79e-10 | 13 | 156 | 6 | GO:0009812 | |
| GeneOntologyBiologicalProcess | estrogen catabolic process | 1.57e-08 | 5 | 156 | 4 | GO:0006711 | |
| GeneOntologyBiologicalProcess | xenobiotic glucuronidation | 1.76e-08 | 12 | 156 | 5 | GO:0052697 | |
| GeneOntologyBiologicalProcess | phenylpropanoid catabolic process | 4.67e-08 | 6 | 156 | 4 | GO:0046271 | |
| GeneOntologyBiologicalProcess | coumarin catabolic process | 4.67e-08 | 6 | 156 | 4 | GO:0046226 | |
| GeneOntologyBiologicalProcess | carboxylic acid metabolic process | PDXDC1 ABCC1 PECR SPR UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 GART UGT1A9 CBS PGK1 FAAH2 UGT1A4 UGT1A1 UGT1A3 LIPC ACAD11 BRCA1 ASAH1 GLO1 ALDH4A1 SMS GAPDHS PC | 6.58e-08 | 1035 | 156 | 26 | GO:0019752 |
| GeneOntologyBiologicalProcess | oxoacid metabolic process | PDXDC1 ABCC1 PECR SPR UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 GART UGT1A9 CBS PGK1 FAAH2 UGT1A4 UGT1A1 UGT1A3 LIPC ACAD11 BRCA1 ASAH1 GLO1 ALDH4A1 SMS GAPDHS PC | 1.01e-07 | 1058 | 156 | 26 | GO:0043436 |
| GeneOntologyBiologicalProcess | organic acid metabolic process | PDXDC1 ABCC1 PECR SPR UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 GART UGT1A9 CBS PGK1 FAAH2 UGT1A4 UGT1A1 UGT1A3 LIPC ACAD11 BRCA1 ASAH1 GLO1 ALDH4A1 SMS GAPDHS PC | 1.13e-07 | 1064 | 156 | 26 | GO:0006082 |
| GeneOntologyBiologicalProcess | phenylpropanoid metabolic process | 6.38e-07 | 10 | 156 | 4 | GO:0009698 | |
| GeneOntologyBiologicalProcess | coumarin metabolic process | 6.38e-07 | 10 | 156 | 4 | GO:0009804 | |
| GeneOntologyBiologicalProcess | estrogen metabolic process | 2.60e-06 | 52 | 156 | 6 | GO:0008210 | |
| GeneOntologyBiologicalProcess | monocarboxylic acid metabolic process | PECR UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 PGK1 FAAH2 UGT1A4 UGT1A1 UGT1A3 LIPC ACAD11 BRCA1 ASAH1 GLO1 GAPDHS PC | 2.83e-06 | 731 | 156 | 19 | GO:0032787 |
| GeneOntologyBiologicalProcess | pigment metabolic process | 7.30e-06 | 94 | 156 | 7 | GO:0042440 | |
| GeneOntologyBiologicalProcess | xenobiotic metabolic process | 1.21e-05 | 141 | 156 | 8 | GO:0006805 | |
| GeneOntologyBiologicalProcess | retinoic acid metabolic process | 1.23e-05 | 40 | 156 | 5 | GO:0042573 | |
| GeneOntologyBiologicalProcess | hormone catabolic process | 1.70e-05 | 21 | 156 | 4 | GO:0042447 | |
| GeneOntologyBiologicalProcess | DNA repair | CDK9 SMG1 USP28 ZGRF1 SMCHD1 PARP2 MSH2 PARP1 PARP4 GTF2H1 BRCA1 BRCA2 FANCI BOD1L1 HERC2 TADA3 | 3.38e-05 | 648 | 156 | 16 | GO:0006281 |
| GeneOntologyBiologicalProcess | replication fork processing | 4.53e-05 | 52 | 156 | 5 | GO:0031297 | |
| GeneOntologyBiologicalProcess | bilirubin conjugation | 5.68e-05 | 2 | 156 | 2 | GO:0006789 | |
| GeneOntologyBiologicalProcess | estrogen receptor signaling pathway | 7.08e-05 | 57 | 156 | 5 | GO:0030520 | |
| GeneOntologyBiologicalProcess | diterpenoid metabolic process | 8.00e-05 | 94 | 156 | 6 | GO:0016101 | |
| GeneOntologyBiologicalProcess | DNA-templated DNA replication maintenance of fidelity | 9.06e-05 | 60 | 156 | 5 | GO:0045005 | |
| GeneOntologyBiologicalProcess | decidualization | 1.09e-04 | 33 | 156 | 4 | GO:0046697 | |
| GeneOntologyBiologicalProcess | porphyrin-containing compound catabolic process | 1.15e-04 | 13 | 156 | 3 | GO:0006787 | |
| GeneOntologyBiologicalProcess | DNA damage response | CDK9 SMG1 MYO6 USP28 ZGRF1 SMCHD1 PARP2 MSH2 PARP1 PARP4 GTF2H1 BRCA1 NUAK1 BRCA2 FANCI ZBTB40 BOD1L1 HERC2 TADA3 | 1.19e-04 | 959 | 156 | 19 | GO:0006974 |
| GeneOntologyBiologicalProcess | steroid catabolic process | 1.22e-04 | 34 | 156 | 4 | GO:0006706 | |
| GeneOntologyBiologicalProcess | tetrapyrrole catabolic process | 1.45e-04 | 14 | 156 | 3 | GO:0033015 | |
| GeneOntologyBiologicalProcess | terpenoid metabolic process | 1.48e-04 | 105 | 156 | 6 | GO:0006721 | |
| GeneOntologyBiologicalProcess | DNA ADP-ribosylation | 1.70e-04 | 3 | 156 | 2 | GO:0030592 | |
| GeneOntologyBiologicalProcess | maternal process involved in female pregnancy | 2.30e-04 | 73 | 156 | 5 | GO:0060135 | |
| GeneOntologyBiologicalProcess | heterochromatin formation | 2.46e-04 | 163 | 156 | 7 | GO:0031507 | |
| GeneOntologyBiologicalProcess | cellular response to xenobiotic stimulus | 2.94e-04 | 222 | 156 | 8 | GO:0071466 | |
| GeneOntologyBiologicalProcess | maternal placenta development | 3.38e-04 | 44 | 156 | 4 | GO:0001893 | |
| GeneOntologyBiologicalProcess | cellular response to steroid hormone stimulus | 4.81e-04 | 239 | 156 | 8 | GO:0071383 | |
| GeneOntologyBiologicalProcess | hormone-mediated signaling pathway | 5.52e-04 | 244 | 156 | 8 | GO:0009755 | |
| GeneOntologyBiologicalProcess | retinoid metabolic process | 5.78e-04 | 89 | 156 | 5 | GO:0001523 | |
| GeneOntologyBiologicalProcess | dosage compensation by inactivation of X chromosome | 5.88e-04 | 22 | 156 | 3 | GO:0009048 | |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated steroid hormone signaling pathway | 5.95e-04 | 136 | 156 | 6 | GO:0030518 | |
| GeneOntologyBiologicalProcess | steroid metabolic process | UGT1A10 UGT1A8 UGT1A7 UGT1A9 UGT1A4 UGT1A1 UGT1A3 LIPC ASAH1 SEC14L2 | 5.98e-04 | 376 | 156 | 10 | GO:0008202 |
| GeneOntologyBiologicalProcess | response to steroid hormone | UGT1A6 NCOA4 UGT1A1 PARP1 KMT2D IGFBP2 BRCA1 UBE3A AGL TADA3 | 6.62e-04 | 381 | 156 | 10 | GO:0048545 |
| GeneOntologyBiologicalProcess | response to xenobiotic stimulus | ABCC1 MYO6 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A9 UGT1A1 UGT1A3 PARP4 IGFBP2 DMD | 6.65e-04 | 525 | 156 | 12 | GO:0009410 |
| GeneOntologyBiologicalProcess | sex-chromosome dosage compensation | 7.64e-04 | 24 | 156 | 3 | GO:0007549 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 1.26e-05 | 290 | 157 | 11 | GO:0043292 | |
| GeneOntologyCellularComponent | myofibril | 4.25e-05 | 273 | 157 | 10 | GO:0030016 | |
| GeneOntologyCellularComponent | Z disc | 1.47e-04 | 151 | 157 | 7 | GO:0030018 | |
| GeneOntologyCellularComponent | supramolecular polymer | COL4A2 FLNB MYL5 MYH13 MYO1A MYO6 KIF26A INPP5D NEB RYR2 PARP4 XIRP2 AHNAK DNAH17 SCN8A DLG1 TTLL1 DMD ASB2 CAMSAP1 ALPG | 2.24e-04 | 1187 | 157 | 21 | GO:0099081 |
| GeneOntologyCellularComponent | I band | 2.64e-04 | 166 | 157 | 7 | GO:0031674 | |
| GeneOntologyCellularComponent | supramolecular fiber | FLNB MYL5 MYH13 MYO1A MYO6 KIF26A INPP5D NEB RYR2 PARP4 XIRP2 AHNAK DNAH17 SCN8A DLG1 TTLL1 DMD ASB2 CAMSAP1 ALPG | 5.47e-04 | 1179 | 157 | 20 | GO:0099512 |
| GeneOntologyCellularComponent | lateral plasma membrane | 5.90e-04 | 90 | 157 | 5 | GO:0016328 | |
| GeneOntologyCellularComponent | DNA repair complex | 6.59e-04 | 23 | 157 | 3 | GO:1990391 | |
| GeneOntologyCellularComponent | myosin complex | 1.01e-03 | 59 | 157 | 4 | GO:0016459 | |
| MousePheno | abnormal gait | PLCZ1 FLNB CTSF MYO6 ZNF423 CANX SPART NEB ATL1 KMT2D NRXN2 UBE3A ASAH1 AGL AFG3L2 SCN8A DMD HELLS | 6.49e-07 | 520 | 123 | 18 | MP:0001406 |
| MousePheno | abnormal axial skeleton morphology | COL4A2 SMG1 FLNB IFT140 EVC2 MYO6 SMCHD1 CEP290 ASH1L NEB CBS USP14 PARP4 KMT2D TENM4 LRIG1 BRCA2 BRDT ASAH1 FANCI AGL SCN8A ZBTB40 KMT2A DLG1 SMS DMD PALS2 CTSV CLUH HELLS | 2.29e-06 | 1458 | 123 | 31 | MP:0002114 |
| MousePheno | abnormal locomotor coordination | PLCZ1 FLNB CTSF MYO6 ZNF423 CANX SPART NEB ATL1 USP14 KMT2D SLC12A2 NRXN2 UBE3A ASAH1 AGL AFG3L2 SCN8A DMD HELLS | 5.04e-06 | 726 | 123 | 20 | MP:0003312 |
| MousePheno | tremors | CTSF SPR VPS4A ZNF423 CANX USP14 TENM4 NRXN2 AGL AFG3L2 SCN8A HERC2 DMD | 1.37e-05 | 353 | 123 | 13 | MP:0000745 |
| MousePheno | abnormal vertebral column morphology | COL4A2 FLNB IFT140 NEB CBS USP14 PARP4 TENM4 LRIG1 BRDT ASAH1 AGL SCN8A ZBTB40 KMT2A SMS DMD PALS2 CLUH HELLS | 1.65e-05 | 787 | 123 | 20 | MP:0004703 |
| MousePheno | muscle weakness | 2.45e-05 | 98 | 123 | 7 | MP:0000747 | |
| MousePheno | early cellular replicative senescence | 3.40e-05 | 70 | 123 | 6 | MP:0008008 | |
| MousePheno | induced chromosome breakage | 6.26e-05 | 25 | 123 | 4 | MP:0004030 | |
| MousePheno | abnormal cellular replicative senescence | 7.25e-05 | 80 | 123 | 6 | MP:0008007 | |
| MousePheno | postnatal growth retardation | FLNB EVC2 KIF26A SPR INPP5D CANX CEP290 ASH1L NEB CBS USP14 SLC12A2 BRCA1 XIRP2 UBE3A ASAH1 KMT2A SMS DMD CTSV | 8.15e-05 | 881 | 123 | 20 | MP:0001732 |
| MousePheno | abnormal intracellular organelle morphology | CEP290 SPART RYR2 ATL1 RAB10 BRCA1 BRCA2 ASAH1 AFG3L2 DKC1 HERC2 CAMSAP1 CTSV CLUH HELLS | 8.86e-05 | 546 | 123 | 15 | MP:0014239 |
| MousePheno | abnormal vertebrae morphology | COL4A2 FLNB IFT140 CBS USP14 PARP4 TENM4 LRIG1 BRDT SCN8A ZBTB40 KMT2A PALS2 CLUH HELLS | 8.86e-05 | 546 | 123 | 15 | MP:0000137 |
| MousePheno | cachexia | 9.48e-05 | 121 | 123 | 7 | MP:0005150 | |
| MousePheno | abnormal postnatal growth | FLNB EVC2 KIF26A SPR INPP5D CANX CEP290 ASH1L NEB CBS USP14 SLC12A2 BRCA1 XIRP2 UBE3A ASAH1 KMT2A SMS DMD CTSV | 1.21e-04 | 907 | 123 | 20 | MP:0001731 |
| MousePheno | limb grasping | CTSF MYO1A SPART GRM7 USP14 KMT2D UBE3A ASAH1 AFG3L2 SCN8A TRPM1 | 1.38e-04 | 325 | 123 | 11 | MP:0001513 |
| MousePheno | abnormal DNA repair | 1.49e-04 | 130 | 123 | 7 | MP:0008058 | |
| MousePheno | abnormal adipose tissue amount | SECISBP2L UBR1 FLNB MYO6 GDAP2 ASH1L SPART NEB UBE4A TENM4 SLC12A2 BRCA1 LRIG1 UBE3A AGL AHNAK DKC1 DMD ASB2 PALS2 PC HELLS | 1.62e-04 | 1077 | 123 | 22 | MP:0005452 |
| MousePheno | abnormal presacral vertebrae morphology | 1.66e-04 | 225 | 123 | 9 | MP:0000459 | |
| MousePheno | paraparesis | 1.70e-04 | 32 | 123 | 4 | MP:0009434 | |
| MousePheno | progressive muscle weakness | 2.16e-04 | 34 | 123 | 4 | MP:0000748 | |
| MousePheno | retina ischemia | 2.29e-04 | 3 | 123 | 2 | MP:0006190 | |
| MousePheno | abnormal adipose tissue morphology | SECISBP2L UBR1 FLNB MYO6 GDAP2 ASH1L SPART NEB UBE4A KMT2D TENM4 SLC12A2 BRCA1 LRIG1 UBE3A ASAH1 AGL AHNAK DKC1 HERC2 DMD ASB2 PALS2 PC HELLS | 2.87e-04 | 1361 | 123 | 25 | MP:0000003 |
| MousePheno | abnormal uterus morphology | PDXDC1 EVC2 MYO6 SMCHD1 CANX ASH1L MSH2 CBS PARP1 BRCA1 UBE3A DLG1 | 2.94e-04 | 415 | 123 | 12 | MP:0001120 |
| MousePheno | hindlimb paresis | 3.01e-04 | 37 | 123 | 4 | MP:0031204 | |
| MousePheno | increased mammary gland tumor incidence | 3.34e-04 | 38 | 123 | 4 | MP:0010299 | |
| MousePheno | abnormal reflex | SECISBP2L CTSF TBC1D9B MYO1A MYO6 TEX2 VPS4A GDAP2 ASH1L SPART GRM7 JAKMIP2 RYR2 USP14 RAB10 KMT2D SLC12A2 FAR2 UBE3A ASAH1 AFG3L2 SCN8A TRPM1 DNMBP | 3.37e-04 | 1294 | 123 | 24 | MP:0001961 |
| MousePheno | adipose tissue phenotype | SECISBP2L UBR1 FLNB MYO6 GDAP2 ASH1L SPART NEB UBE4A KMT2D TENM4 SLC12A2 BRCA1 LRIG1 UBE3A ASAH1 AGL AHNAK DKC1 HERC2 DMD ASB2 PALS2 PC HELLS | 3.67e-04 | 1383 | 123 | 25 | MP:0005375 |
| MousePheno | chromosomal instability | 3.97e-04 | 109 | 123 | 6 | MP:0008866 | |
| MousePheno | abnormal exocrine gland morphology | PDXDC1 ASH1L SLC26A9 MSH2 CBS ATL1 MFSD14A PARP1 SLC12A2 FAR2 BRCA1 BRCA2 BRDT UBE3A DKC1 DLG1 CTSV CLUH | 4.67e-04 | 853 | 123 | 18 | MP:0013558 |
| MousePheno | abnormal auditory brainstem response waveform shape | 4.93e-04 | 42 | 123 | 4 | MP:0011966 | |
| Domain | UDPGT | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 3.99e-14 | 21 | 155 | 9 | PF00201 |
| Domain | UDPGT | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 3.99e-14 | 21 | 155 | 9 | PS00375 |
| Domain | UDP_glucos_trans | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 3.99e-14 | 21 | 155 | 9 | IPR002213 |
| Domain | PARP_ALPHA_HD | 2.23e-06 | 4 | 155 | 3 | PS51060 | |
| Domain | Poly(ADP-ribose)pol_reg_dom | 2.23e-06 | 4 | 155 | 3 | IPR004102 | |
| Domain | - | 2.23e-06 | 4 | 155 | 3 | 1.20.142.10 | |
| Domain | BRCT | 1.60e-05 | 19 | 155 | 4 | PF00533 | |
| Domain | BRCT | 2.97e-05 | 22 | 155 | 4 | SM00292 | |
| Domain | - | 3.57e-05 | 23 | 155 | 4 | 3.40.50.10190 | |
| Domain | BRCT | 5.92e-05 | 26 | 155 | 4 | PS50172 | |
| Domain | BRCT_dom | 8.00e-05 | 28 | 155 | 4 | IPR001357 | |
| Domain | WGR | 2.04e-04 | 3 | 155 | 2 | SM00773 | |
| Domain | PARP_reg | 2.04e-04 | 3 | 155 | 2 | PF02877 | |
| Domain | WGR | 2.04e-04 | 3 | 155 | 2 | PF05406 | |
| Domain | - | 2.04e-04 | 3 | 155 | 2 | 2.20.140.10 | |
| Domain | Post-SET_dom | 2.90e-04 | 16 | 155 | 3 | IPR003616 | |
| Domain | PostSET | 2.90e-04 | 16 | 155 | 3 | SM00508 | |
| Domain | POST_SET | 2.90e-04 | 16 | 155 | 3 | PS50868 | |
| Domain | Poly(ADP-ribose)pol_cat_dom | 3.50e-04 | 17 | 155 | 3 | IPR012317 | |
| Domain | PARP_CATALYTIC | 3.50e-04 | 17 | 155 | 3 | PS51059 | |
| Domain | PARP | 3.50e-04 | 17 | 155 | 3 | PF00644 | |
| Domain | - | 3.50e-04 | 17 | 155 | 3 | 3.90.228.10 | |
| Domain | FYrich_C | 6.73e-04 | 5 | 155 | 2 | IPR003889 | |
| Domain | FYrich_N | 6.73e-04 | 5 | 155 | 2 | IPR003888 | |
| Domain | FYRC | 6.73e-04 | 5 | 155 | 2 | SM00542 | |
| Domain | FYRN | 6.73e-04 | 5 | 155 | 2 | SM00541 | |
| Domain | FYRN | 6.73e-04 | 5 | 155 | 2 | PF05964 | |
| Domain | FYRC | 6.73e-04 | 5 | 155 | 2 | PF05965 | |
| Domain | FYRC | 6.73e-04 | 5 | 155 | 2 | PS51543 | |
| Domain | FYRN | 6.73e-04 | 5 | 155 | 2 | PS51542 | |
| Domain | WGR_domain | 9.98e-04 | 24 | 155 | 3 | IPR008893 | |
| Domain | Rudment_hybrid_motif | 1.00e-03 | 6 | 155 | 2 | IPR011054 | |
| Domain | Prot_inhib_I29 | 1.40e-03 | 7 | 155 | 2 | IPR013201 | |
| Domain | APC_su10/DOC_dom | 1.40e-03 | 7 | 155 | 2 | IPR004939 | |
| Domain | DOC | 1.40e-03 | 7 | 155 | 2 | PS51284 | |
| Domain | ANAPC10 | 1.40e-03 | 7 | 155 | 2 | PF03256 | |
| Domain | Inhibitor_I29 | 1.40e-03 | 7 | 155 | 2 | PF08246 | |
| Domain | Inhibitor_I29 | 1.40e-03 | 7 | 155 | 2 | SM00848 | |
| Domain | APC10 | 1.40e-03 | 7 | 155 | 2 | SM01337 | |
| Domain | AT_hook | 1.42e-03 | 27 | 155 | 3 | SM00384 | |
| Domain | AT_hook_DNA-bd_motif | 1.42e-03 | 27 | 155 | 3 | IPR017956 | |
| Domain | VIT | 1.85e-03 | 8 | 155 | 2 | PF08487 | |
| Domain | VIT | 1.85e-03 | 8 | 155 | 2 | SM00609 | |
| Domain | P-loop_NTPase | ABCC1 MYH13 MYO1A MYO6 KIF26A VPS4A ZGRF1 RNF213 MSH2 ARHGAP35 ATL1 RAB10 AFG3L2 DLG1 PALS2 HELLS | 1.86e-03 | 848 | 155 | 16 | IPR027417 |
| Domain | ATP_grasp_subdomain_2 | 2.12e-03 | 31 | 155 | 3 | IPR013816 | |
| Domain | IQ | 2.88e-03 | 71 | 155 | 4 | PF00612 | |
| Domain | MIT | 2.95e-03 | 10 | 155 | 2 | SM00745 | |
| Domain | VIT | 2.95e-03 | 10 | 155 | 2 | PS51468 | |
| Domain | VIT | 2.95e-03 | 10 | 155 | 2 | IPR013694 | |
| Domain | MIT | 2.95e-03 | 10 | 155 | 2 | PF04212 | |
| Domain | PHD | 3.51e-03 | 75 | 155 | 4 | PF00628 | |
| Domain | Pept_his_AS | 3.58e-03 | 11 | 155 | 2 | IPR025660 | |
| Domain | Filamin | 3.58e-03 | 11 | 155 | 2 | PF00630 | |
| Domain | FILAMIN_REPEAT | 3.58e-03 | 11 | 155 | 2 | PS50194 | |
| Domain | Filamin/ABP280_rpt | 3.58e-03 | 11 | 155 | 2 | IPR001298 | |
| Domain | Filamin/ABP280_repeat-like | 3.58e-03 | 11 | 155 | 2 | IPR017868 | |
| Domain | Myosin_head_motor_dom | 3.82e-03 | 38 | 155 | 3 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 3.82e-03 | 38 | 155 | 3 | PS51456 | |
| Domain | Myosin_head | 3.82e-03 | 38 | 155 | 3 | PF00063 | |
| Domain | MYSc | 3.82e-03 | 38 | 155 | 3 | SM00242 | |
| Domain | Znf_PHD-finger | 4.23e-03 | 79 | 155 | 4 | IPR019787 | |
| Domain | - | UBR1 MYCBP2 KDM5A ZNF423 ASH1L RNF213 UBE4A KMT2D BRCA1 KMT2A | 4.33e-03 | 449 | 155 | 10 | 3.30.40.10 |
| Domain | IQ | 4.63e-03 | 81 | 155 | 4 | SM00015 | |
| Domain | SET | 4.74e-03 | 41 | 155 | 3 | PF00856 | |
| Domain | BROMODOMAIN_2 | 4.74e-03 | 41 | 155 | 3 | PS50014 | |
| Domain | - | 5.03e-03 | 13 | 155 | 2 | 1.20.58.280 | |
| Domain | L27 | 5.03e-03 | 13 | 155 | 2 | SM00569 | |
| Domain | L27 | 5.03e-03 | 13 | 155 | 2 | PS51022 | |
| Domain | L27_dom | 5.03e-03 | 13 | 155 | 2 | IPR004172 | |
| Domain | - | 5.03e-03 | 13 | 155 | 2 | 3.40.50.20 | |
| Domain | Pept_C1 | 5.03e-03 | 13 | 155 | 2 | SM00645 | |
| Domain | Peptidase_C1A_C | 5.03e-03 | 13 | 155 | 2 | IPR000668 | |
| Domain | Peptidase_C1 | 5.03e-03 | 13 | 155 | 2 | PF00112 | |
| Domain | Peptidase_C1A | 5.03e-03 | 13 | 155 | 2 | IPR013128 | |
| Domain | Znf_RING/FYVE/PHD | UBR1 MYCBP2 KDM5A ZNF423 ASH1L RNF213 UBE4A KMT2D BRCA1 KMT2A | 5.05e-03 | 459 | 155 | 10 | IPR013083 |
| Domain | Bromodomain | 5.08e-03 | 42 | 155 | 3 | IPR001487 | |
| Domain | BROMO | 5.08e-03 | 42 | 155 | 3 | SM00297 | |
| Domain | - | 5.08e-03 | 42 | 155 | 3 | 1.20.920.10 | |
| Domain | MIT | 5.83e-03 | 14 | 155 | 2 | IPR007330 | |
| Domain | ATP_GRASP | 5.83e-03 | 14 | 155 | 2 | PS50975 | |
| Domain | ATP-grasp | 5.83e-03 | 14 | 155 | 2 | IPR011761 | |
| Domain | PreATP-grasp_dom | 5.83e-03 | 14 | 155 | 2 | IPR016185 | |
| Domain | PHD | 6.45e-03 | 89 | 155 | 4 | SM00249 | |
| Domain | PDZ | 6.46e-03 | 141 | 155 | 5 | PF00595 | |
| Domain | SET | 6.55e-03 | 46 | 155 | 3 | SM00317 | |
| Domain | - | 6.69e-03 | 15 | 155 | 2 | 3.30.1490.20 | |
| Domain | IQ_motif_EF-hand-BS | 6.71e-03 | 90 | 155 | 4 | IPR000048 | |
| Domain | Znf_PHD | 6.98e-03 | 91 | 155 | 4 | IPR001965 | |
| Domain | IQ | 7.52e-03 | 93 | 155 | 4 | PS50096 | |
| Domain | Guanylate_kinase_CS | 7.61e-03 | 16 | 155 | 2 | IPR020590 | |
| Domain | PDZ | 7.89e-03 | 148 | 155 | 5 | SM00228 | |
| Domain | ZF_PHD_2 | 8.10e-03 | 95 | 155 | 4 | PS50016 | |
| Domain | SET_dom | 8.26e-03 | 50 | 155 | 3 | IPR001214 | |
| Domain | SET | 8.26e-03 | 50 | 155 | 3 | PS50280 | |
| Pathway | REACTOME_GLUCURONIDATION | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 8.67e-13 | 25 | 134 | 9 | M17787 |
| Pathway | KEGG_ASCORBATE_AND_ALDARATE_METABOLISM | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 8.67e-13 | 25 | 134 | 9 | M605 |
| Pathway | WP_GLUCURONIDATION | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.32e-12 | 26 | 134 | 9 | M39404 |
| Pathway | KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 2.86e-12 | 28 | 134 | 9 | M19580 |
| Pathway | REACTOME_GLUCURONIDATION | 3.49e-11 | 24 | 134 | 8 | MM14599 | |
| Pathway | KEGG_STARCH_AND_SUCROSE_METABOLISM | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 AGL | 4.84e-11 | 52 | 134 | 10 | M14171 |
| Pathway | WP_GLUCURONIDATION | 5.10e-11 | 25 | 134 | 8 | MM15820 | |
| Pathway | KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.31e-10 | 41 | 134 | 9 | M7399 |
| Pathway | WP_ESTROGEN_METABOLISM | 9.07e-10 | 22 | 134 | 7 | MM15888 | |
| Pathway | KEGG_DRUG_METABOLISM_OTHER_ENZYMES | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.05e-09 | 51 | 134 | 9 | M17726 |
| Pathway | KEGG_STEROID_HORMONE_BIOSYNTHESIS | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 2.12e-09 | 55 | 134 | 9 | M14933 |
| Pathway | REACTOME_ASPIRIN_ADME | 7.18e-09 | 44 | 134 | 8 | M45014 | |
| Pathway | KEGG_RETINOL_METABOLISM | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 8.56e-09 | 64 | 134 | 9 | M9488 |
| Pathway | REACTOME_ASPIRIN_ADME | 8.66e-09 | 45 | 134 | 8 | MM15694 | |
| Pathway | KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450 | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.93e-08 | 70 | 134 | 9 | M16794 |
| Pathway | KEGG_DRUG_METABOLISM_CYTOCHROME_P450 | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 2.48e-08 | 72 | 134 | 9 | M9257 |
| Pathway | REACTOME_DRUG_ADME | ABCC1 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 8.24e-08 | 109 | 134 | 10 | M45012 |
| Pathway | WP_CODEINE_AND_MORPHINE_METABOLISM | 1.35e-07 | 14 | 134 | 5 | M39328 | |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 9.24e-07 | 109 | 134 | 9 | M18788 |
| Pathway | REACTOME_HEME_DEGRADATION | 9.95e-07 | 20 | 134 | 5 | MM14721 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 1.66e-06 | 39 | 134 | 6 | MM15695 | |
| Pathway | REACTOME_DRUG_ADME | ABCC1 UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.93e-06 | 119 | 134 | 9 | MM15692 |
| Pathway | WP_IRINOTECAN_PATHWAY | 3.64e-06 | 12 | 134 | 4 | M39611 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 7.12e-06 | 29 | 134 | 5 | M45015 | |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | 8.00e-06 | 107 | 134 | 8 | MM14595 | |
| Pathway | REACTOME_METABOLISM_OF_PORPHYRINS | 1.18e-05 | 32 | 134 | 5 | MM14719 | |
| Pathway | WP_ESTROGEN_METABOLISM_WP697 | 2.15e-05 | 18 | 134 | 4 | M39424 | |
| Pathway | WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2873 | 6.48e-05 | 45 | 134 | 5 | M39615 | |
| Pathway | WP_METAPATHWAY_BIOTRANSFORMATION | 1.05e-04 | 153 | 134 | 8 | MM15844 | |
| Pathway | WP_DNA_IRDAMAGE_AND_CELLULAR_RESPONSE_VIA_ATR | 1.19e-04 | 81 | 134 | 6 | M39490 | |
| Pathway | WP_DNA_REPAIR_PATHWAYS_FULL_NETWORK | 1.46e-04 | 120 | 134 | 7 | M40049 | |
| Pathway | REACTOME_HDR_THROUGH_MMEJ_ALT_NHEJ | 1.74e-04 | 12 | 134 | 3 | M27569 | |
| Pathway | REACTOME_HDR_THROUGH_MMEJ_ALT_NHEJ | 1.74e-04 | 12 | 134 | 3 | MM15282 | |
| Pathway | WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY | 2.01e-04 | 31 | 134 | 4 | M39476 | |
| Pathway | WP_PREGNANE_X_RECEPTOR_PATHWAY | 2.28e-04 | 32 | 134 | 4 | M39567 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 2.52e-04 | 220 | 134 | 9 | M10320 |
| Pathway | REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_DNA_REPAIR_GENES | 3.02e-04 | 62 | 134 | 5 | M27618 | |
| Pathway | REACTOME_HEME_DEGRADATION | 3.51e-04 | 15 | 134 | 3 | M27060 | |
| Pathway | REACTOME_ATORVASTATIN_ADME | 3.51e-04 | 15 | 134 | 3 | MM15697 | |
| Pathway | WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II | 3.59e-04 | 183 | 134 | 8 | M39588 | |
| Pathway | KEGG_MEDICUS_REFERENCE_HOMOLOGOUS_RECOMBINATION_IN_ICLR | 4.30e-04 | 16 | 134 | 3 | M47855 | |
| Pathway | REACTOME_FORMATION_OF_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES | 4.48e-04 | 38 | 134 | 4 | MM17073 | |
| Pathway | WP_2Q37_COPY_NUMBER_VARIATION_SYNDROME | 4.66e-04 | 145 | 134 | 7 | M45512 | |
| Pathway | REACTOME_FORMATION_OF_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES | 6.60e-04 | 42 | 134 | 4 | M48018 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS | 8.23e-04 | 77 | 134 | 5 | M27226 | |
| Pathway | WP_TAMOXIFEN_METABOLISM | 9.85e-04 | 21 | 134 | 3 | M39631 | |
| Pathway | REACTOME_GLUCOSE_METABOLISM | 1.09e-03 | 82 | 134 | 5 | MM15394 | |
| Pathway | WP_NAD_BIOSYNTHETIC_PATHWAYS | 1.13e-03 | 22 | 134 | 3 | M39704 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 1.17e-03 | 219 | 134 | 8 | MM14838 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS | 1.22e-03 | 84 | 134 | 5 | MM14929 | |
| Pathway | REACTOME_GLUCOSE_METABOLISM | 1.29e-03 | 85 | 134 | 5 | M1870 | |
| Pathway | REACTOME_PREDNISONE_ADME | 1.29e-03 | 23 | 134 | 3 | MM16639 | |
| Pathway | WP_ARYLAMINE_METABOLISM | 1.31e-03 | 6 | 134 | 2 | M39437 | |
| Pathway | WP_NICOTINE_METABOLISM_IN_LIVER_CELLS | 1.31e-03 | 6 | 134 | 2 | M39600 | |
| Pathway | REACTOME_GLUCONEOGENESIS | 1.86e-03 | 26 | 134 | 3 | MM15392 | |
| Pathway | REACTOME_GLUCONEOGENESIS | 1.86e-03 | 26 | 134 | 3 | M13748 | |
| Pathway | REACTOME_METABOLISM_OF_PORPHYRINS | 2.08e-03 | 27 | 134 | 3 | M1088 | |
| Pubmed | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 7.35e-22 | 9 | 160 | 9 | 22511988 | |
| Pubmed | A genome-wide assessment of variability in human serum metabolism. | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 LIPC ACAD11 | 1.01e-21 | 19 | 160 | 11 | 23281178 |
| Pubmed | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 7.32e-21 | 10 | 160 | 9 | 23642732 | |
| Pubmed | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 7.32e-21 | 10 | 160 | 9 | 11465080 | |
| Pubmed | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 7.32e-21 | 10 | 160 | 9 | 23371916 | |
| Pubmed | A genome-wide association study of total bilirubin and cholelithiasis risk in sickle cell anemia. | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 7.32e-21 | 10 | 160 | 9 | 22558097 |
| Pubmed | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.60e-19 | 12 | 160 | 9 | 19419973 | |
| Pubmed | Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus. | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.60e-19 | 12 | 160 | 9 | 11434514 |
| Pubmed | 1.68e-19 | 8 | 160 | 8 | 20610558 | ||
| Pubmed | 1.68e-19 | 8 | 160 | 8 | 17179145 | ||
| Pubmed | UGT1A1 is a major locus influencing bilirubin levels in African Americans. | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 5.17e-19 | 13 | 160 | 9 | 22085899 |
| Pubmed | Genome-wide analysis of hepatic lipid content in extreme obesity. | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 5.17e-19 | 13 | 160 | 9 | 25246029 |
| Pubmed | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.44e-18 | 14 | 160 | 9 | 21646302 | |
| Pubmed | Human UDP-glucuronosyltransferases: metabolism, expression, and disease. | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.44e-18 | 14 | 160 | 9 | 10836148 |
| Pubmed | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.44e-18 | 14 | 160 | 9 | 9295054 | |
| Pubmed | Multiple variable first exons: a mechanism for cell- and tissue-specific gene regulation. | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.44e-18 | 14 | 160 | 9 | 14672974 |
| Pubmed | Genome-wide association meta-analysis for total serum bilirubin levels. | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 8.18e-18 | 16 | 160 | 9 | 19414484 |
| Pubmed | Genome-wide association of serum bilirubin levels in Korean population. | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.73e-17 | 17 | 160 | 9 | 20639394 |
| Pubmed | Assignment of the human UDP glucuronosyltransferase gene (UGT1A1) to chromosome region 2q37. | 3.82e-17 | 7 | 160 | 7 | 8467709 | |
| Pubmed | 3.82e-17 | 7 | 160 | 7 | 8464825 | ||
| Pubmed | Role of UDP-glucuronosyltransferase isoforms in 13-cis retinoic acid metabolism in humans. | 8.19e-17 | 12 | 160 | 8 | 20308471 | |
| Pubmed | Genetic determinants influencing human serum metabolome among African Americans. | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 9.06e-16 | 24 | 160 | 9 | 24625756 |
| Pubmed | 1.36e-15 | 9 | 160 | 7 | 1339448 | ||
| Pubmed | Analysis of inherited genetic variations at the UGT1 locus in the French-Canadian population. | 8.63e-15 | 6 | 160 | 6 | 19204906 | |
| Pubmed | Human metabolic individuality in biomedical and pharmaceutical research. | PDXDC1 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.15e-13 | 57 | 160 | 10 | 21886157 |
| Pubmed | 2.40e-13 | 8 | 160 | 6 | 18052087 | ||
| Pubmed | PDXDC1 ABCC1 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 CBS UGT1A4 UGT1A1 UGT1A3 GTF2H1 LIPC | 2.98e-13 | 190 | 160 | 14 | 24816252 | |
| Pubmed | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 ALDH4A1 | 5.40e-13 | 66 | 160 | 10 | 19898482 | |
| Pubmed | 1.94e-12 | 5 | 160 | 5 | 15057901 | ||
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | PDXDC1 COL4A2 FLNB UAP1 MYCBP2 CANX GART ASH1L NCL PGK1 USP14 RAB10 PARP1 IARS2 SLC12A2 AHNAK GLO1 SCN8A KMT2A SMS UQCRFS1 PALS2 PC | 3.43e-12 | 807 | 160 | 23 | 30575818 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | ZNF384 MYO6 USP28 SMCHD1 GART SPART RPS19 NCL ARHGAP35 CBS PGK1 USP14 PARP1 IARS2 AHNAK GLO1 PES1 AFG3L2 DKC1 KMT2A BOD1L1 CAMSAP1 PC HELLS | 9.69e-12 | 934 | 160 | 24 | 33916271 |
| Pubmed | 1.16e-11 | 6 | 160 | 5 | 20297805 | ||
| Pubmed | Discovery and refinement of loci associated with lipid levels. | PDXDC1 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 LIPC ACAD11 BRCA2 | 2.08e-11 | 211 | 160 | 13 | 24097068 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | HSPE1 FLNB MYO6 VPS4A SMCHD1 CANX GART MRPS35 RPS19 NCL MSH2 CBS PGK1 UBE4A TGM3 PARP1 IARS2 THADA AAAS FANCI GLO1 PES1 DKC1 BOD1L1 NUP188 PC CLUH HELLS | 8.21e-11 | 1425 | 160 | 28 | 30948266 |
| Pubmed | 1.07e-10 | 8 | 160 | 5 | 22579593 | ||
| Pubmed | Involvement of human UGT2B7 and 2B15 in rofecoxib metabolism. | 1.07e-10 | 8 | 160 | 5 | 12695355 | |
| Pubmed | HSPE1 SMG1 FLNB MYH13 MYO1A KDM5A SMCHD1 ASH1L MRPS35 RPS19 NCL NEB PGK1 RYR2 RAB10 PARP1 BRCA1 AHNAK PES1 ANKRD30A DKC1 KMT2A DLG1 CFAP74 BOD1L1 TTLL1 DMD PICK1 | 1.08e-10 | 1442 | 160 | 28 | 35575683 | |
| Pubmed | 1.53e-10 | 18 | 160 | 6 | 20056724 | ||
| Pubmed | 4.31e-10 | 4 | 160 | 4 | 15855726 | ||
| Pubmed | Chromosomal mapping of a human phenol UDP-glucuronosyltransferase, GNT1. | 4.31e-10 | 4 | 160 | 4 | 2108603 | |
| Pubmed | 4.31e-10 | 4 | 160 | 4 | 8280139 | ||
| Pubmed | 4.31e-10 | 4 | 160 | 4 | 1634050 | ||
| Pubmed | 4.31e-10 | 4 | 160 | 4 | 8276413 | ||
| Pubmed | Genetic variations and haplotypes of UDP-glucuronosyltransferase 1A locus in a Korean population. | 4.31e-10 | 4 | 160 | 4 | 18223459 | |
| Pubmed | 4.31e-10 | 4 | 160 | 4 | 1898728 | ||
| Pubmed | 4.31e-10 | 4 | 160 | 4 | 9535849 | ||
| Pubmed | 4.31e-10 | 4 | 160 | 4 | 9271343 | ||
| Pubmed | 4.31e-10 | 4 | 160 | 4 | 17558305 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | UBR1 ZNF384 FLNB MYCBP2 MYO6 SPR VPS4A SMCHD1 GART RPS19 NCL MSH2 PGK1 USP14 TGM3 PARP1 GTF2H1 AAAS UBE3A FANCI ARHGEF1 AHNAK PES1 AFG3L2 DKC1 HERC2 | 6.78e-10 | 1353 | 160 | 26 | 29467282 |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | UBR1 HSPE1 ZNF384 FLNB UAP1 SPR CANX GART SPART RNF213 RPS19 NCL PGK1 USP14 RAB10 TGM3 PARP1 IARS2 AAAS ASAH1 AGL AHNAK DLG1 UQCRFS1 PC CLUH | 8.42e-10 | 1367 | 160 | 26 | 32687490 |
| Pubmed | 8.74e-10 | 11 | 160 | 5 | 18695635 | ||
| Pubmed | PDXDC1 HSPE1 FLNB MYCBP2 SPR SMCHD1 CANX GART SPART TNIP1 RPS19 NCL NCOA4 CBS PARP1 ARHGEF1 AHNAK GLO1 PES1 AFG3L2 CDYL BOD1L1 NUP188 CLUH HELLS | 1.41e-09 | 1297 | 160 | 25 | 33545068 | |
| Pubmed | 1.49e-09 | 12 | 160 | 5 | 18161889 | ||
| Pubmed | FLNB MYCBP2 SMCHD1 CANX GART RPS19 NCL MSH2 PGK1 TGM3 IARS2 FANCI AHNAK PES1 KMT2A NUP188 HERC2 CLUH | 1.53e-09 | 653 | 160 | 18 | 22586326 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | FLNB MYCBP2 SMCHD1 CANX CEP290 GART RPS19 NCL MSH2 PGK1 RAB10 PARP1 AAAS SLC12A2 AHNAK GLO1 PES1 AFG3L2 DKC1 NUP188 HERC2 HELLS | 2.15e-09 | 1024 | 160 | 22 | 24711643 |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | CDK9 PDXDC1 ACP6 MYCBP2 MYO6 VPS4A CANX GART SPART RPS19 NCL MSH2 CBS PARP1 IARS2 AAAS UBE3A FANCI AGL PES1 AFG3L2 DKC1 NUP188 HELLS | 3.77e-09 | 1257 | 160 | 24 | 37317656 |
| Pubmed | 6.42e-09 | 6 | 160 | 4 | 32527940 | ||
| Pubmed | ABCC1 ZNF536 MYCBP2 TEX2 CEP290 RNF213 NCOA4 DENND4C ATL1 USP14 IARS2 AAAS SLC12A2 PES1 DLG1 BOD1L1 CAMSAP1 CLUH | 9.21e-09 | 733 | 160 | 18 | 34672954 | |
| Pubmed | 1.30e-08 | 234 | 160 | 11 | 36243803 | ||
| Pubmed | 1.49e-08 | 7 | 160 | 4 | 27514509 | ||
| Pubmed | COL4A2 SMG1 FLNB EVC2 MYCBP2 MYO6 CANX ASH1L SPART TNIP1 RYR2 KMT2D UBE3A HERC2 ASB2 CAMSAP1 | 1.68e-08 | 591 | 160 | 16 | 15231748 | |
| Pubmed | ABCC1 MYCBP2 CANX CEP290 RNF213 MSH2 RAB10 PARP1 KMT2D AAAS SLC12A2 FANCI AHNAK PES1 AFG3L2 DLG1 HERC2 DMD PC SNTB1 HELLS | 1.75e-08 | 1049 | 160 | 21 | 27880917 | |
| Pubmed | PDXDC1 HSPE1 MYH13 MYO6 RNF213 RPS19 NCL PGK1 RYR2 IARS2 THADA SLC12A2 BRCA1 AHNAK DLG1 CAMSAP1 PC HELLS | 2.24e-08 | 777 | 160 | 18 | 35844135 | |
| Pubmed | SECISBP2L PDXDC1 MYCBP2 VPS4A SPART CBS PARP4 IARS2 AAAS BRCA2 FANCI AGL AFG3L2 UQCRFS1 HERC2 PC | 2.38e-08 | 606 | 160 | 16 | 36538041 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | PDXDC1 HSPE1 MYCBP2 MYO6 TEX2 CANX MRPS35 RNF213 NCL ATL1 RAB10 UBE4A PARP1 IARS2 THADA AAAS SLC12A2 GLO1 AFG3L2 DKC1 ALDH4A1 NUP188 UQCRFS1 HERC2 CLUH | 2.40e-08 | 1496 | 160 | 25 | 32877691 |
| Pubmed | 2.98e-08 | 8 | 160 | 4 | 15319294 | ||
| Pubmed | PDXDC1 HSPE1 ZNF384 ABCC1 FLNB SMCHD1 CANX MRPS35 RPS19 NCL ITIH2 UGT1A1 PARP1 KMT2D DKC1 KMT2A ALDH4A1 | 3.59e-08 | 711 | 160 | 17 | 33022573 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | CDK9 HSPE1 FLNB SPR SMCHD1 CANX GART MRPS35 RPS19 NCL MSH2 ARHGAP35 CBS PGK1 PARP1 ARHGEF1 AGL AHNAK AFG3L2 DKC1 PC CTSV CLUH HELLS | 3.59e-08 | 1415 | 160 | 24 | 28515276 |
| Pubmed | Substrate and functional diversity of lysine acetylation revealed by a proteomics survey. | UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 UGT1A3 ACAD11 AFG3L2 ALDH4A1 PC | 3.91e-08 | 203 | 160 | 10 | 16916647 |
| Pubmed | 4.01e-08 | 108 | 160 | 8 | 19956635 | ||
| Pubmed | CDK9 ZNF384 MYCBP2 SPR INPP5D SMCHD1 MSH2 PGK1 USP14 RAB10 PARP1 KMT2D BRCA1 FANCI GLO1 PES1 ZBTB40 KMT2A SMS TADA3 HELLS | 4.10e-08 | 1103 | 160 | 21 | 34189442 | |
| Pubmed | SMG1 ABCC1 FLNB TBC1D9B VPS4A CANX PARP2 MRPS35 RNF213 MSH2 USP14 UBE4A PARP1 IARS2 THADA AAAS FANCI AHNAK PES1 AFG3L2 DKC1 KMT2A NUP188 HELLS | 4.98e-08 | 1440 | 160 | 24 | 30833792 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | PDXDC1 ABCC1 TBC1D9B MYO6 VPS4A CANX MSH2 USP14 RAB10 THADA AAAS SLC12A2 LRIG1 UBE3A FANCI ARHGEF1 PES1 NUP188 HELLS | 7.86e-08 | 942 | 160 | 19 | 31073040 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | CDK9 FLNB MYO6 SMCHD1 CANX PARP2 GART MRPS35 RPS19 NCL MSH2 PGK1 ITIH2 TGM3 PARP1 IARS2 GTF2H1 AHNAK PES1 AFG3L2 DLG1 GAPDHS | 8.25e-08 | 1257 | 160 | 22 | 36526897 |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | SMG1 FLNB SMCHD1 NCL MSH2 ARHGAP35 ATL1 RAB10 PARP1 AAAS AHNAK GLO1 BOD1L1 SMS | 8.70e-08 | 498 | 160 | 14 | 36634849 |
| Pubmed | Glucuronidation of psilocin and 4-hydroxyindole by the human UDP-glucuronosyltransferases. | 9.56e-08 | 3 | 160 | 3 | 20007669 | |
| Pubmed | 9.56e-08 | 3 | 160 | 3 | 12051676 | ||
| Pubmed | 9.56e-08 | 3 | 160 | 3 | 31916449 | ||
| Pubmed | 9.56e-08 | 3 | 160 | 3 | 19364970 | ||
| Pubmed | 9.56e-08 | 3 | 160 | 3 | 29519853 | ||
| Pubmed | 9.56e-08 | 3 | 160 | 3 | 11179460 | ||
| Pubmed | 9.56e-08 | 3 | 160 | 3 | 12732365 | ||
| Pubmed | 9.56e-08 | 3 | 160 | 3 | 20860988 | ||
| Pubmed | 9.56e-08 | 3 | 160 | 3 | 19712005 | ||
| Pubmed | 9.56e-08 | 3 | 160 | 3 | 19303655 | ||
| Pubmed | 9.56e-08 | 3 | 160 | 3 | 22586318 | ||
| Pubmed | 9.56e-08 | 3 | 160 | 3 | 16636344 | ||
| Pubmed | 9.56e-08 | 3 | 160 | 3 | 25639900 | ||
| Pubmed | 9.56e-08 | 3 | 160 | 3 | 17406868 | ||
| Pubmed | 9.56e-08 | 3 | 160 | 3 | 19996319 | ||
| Pubmed | 9.56e-08 | 3 | 160 | 3 | 25865228 | ||
| Pubmed | 9.56e-08 | 3 | 160 | 3 | 12847094 | ||
| Pubmed | Linkage disequilibrium of UGT1A1 *6 and UGT1A1 *28 in relation to UGT1A6 and UGT1A7 polymorphisms. | 9.56e-08 | 3 | 160 | 3 | 16969497 | |
| Pubmed | 9.56e-08 | 3 | 160 | 3 | 15247627 | ||
| Pubmed | 9.56e-08 | 3 | 160 | 3 | 26247833 | ||
| Pubmed | Differences in UGT1A1, UGT1A7, and UGT1A9 polymorphisms between Uzbek and Japanese populations. | 9.56e-08 | 3 | 160 | 3 | 24453052 | |
| Pubmed | 9.56e-08 | 3 | 160 | 3 | 23789755 | ||
| Pubmed | Synthetic lethality of PARP inhibition in cancers lacking BRCA1 and BRCA2 mutations. | 9.56e-08 | 3 | 160 | 3 | 21487248 | |
| Pubmed | Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair. | ZNF384 SMCHD1 GART SPART NCL TGM3 PARP1 BRCA1 BRCA2 FANCI PC HELLS | 1.13e-07 | 357 | 160 | 12 | 37059091 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | ABCC1 KDM5A SMCHD1 PARP2 CEP290 RPS19 NCL MSH2 PARP1 KMT2D AAAS BRCA1 AHNAK AFG3L2 DKC1 KMT2A CDYL NUP188 PC TADA3 RSL24D1 HELLS | 1.36e-07 | 1294 | 160 | 22 | 30804502 |
| Interaction | H3C1 interactions | CDK9 HSPE1 PLCZ1 MYO6 KDM5A SMCHD1 PARP2 CEP290 ASH1L MRPS35 TNIP1 MSH2 NEB ITIH2 PARP1 KMT2D XIRP2 WDR87 AHNAK PES1 DKC1 KMT2A CDYL CAMSAP1 HELLS | 3.19e-08 | 901 | 157 | 25 | int:H3C1 |
| Interaction | NAA40 interactions | ZNF384 MYO6 USP28 SMCHD1 PARP2 GART SPART RPS19 NCL ARHGAP35 CBS PGK1 USP14 PARP1 IARS2 AHNAK GLO1 PES1 AFG3L2 DKC1 KMT2A BOD1L1 CAMSAP1 PC HELLS | 1.54e-07 | 978 | 157 | 25 | int:NAA40 |
| Interaction | AGR2 interactions | CDK9 PDXDC1 COL4A2 FLNB UAP1 MYCBP2 CANX GART ASH1L NCL PGK1 USP14 RAB10 PARP1 IARS2 SLC12A2 AHNAK GLO1 SCN8A KMT2A SMS UQCRFS1 PALS2 PC | 2.56e-07 | 934 | 157 | 24 | int:AGR2 |
| Interaction | PFN1 interactions | CDK9 HSPE1 SPR TEX2 TNIP1 NCL ARHGAP35 PGK1 DENND4C USP14 PARP1 THADA BRCA1 ARHGEF1 BOD1L1 ASB2 DNMBP | 5.00e-07 | 509 | 157 | 17 | int:PFN1 |
| Interaction | STIP1 interactions | CDK9 PDXDC1 HSPE1 FLNB EVC2 TEX2 CANX GART RPS19 MSH2 NEB CBS PGK1 DENND4C PARP1 BRCA1 FANCI AHNAK GLO1 PES1 DKC1 NUP188 HELLS | 3.42e-06 | 1006 | 157 | 23 | int:STIP1 |
| Interaction | LRRC31 interactions | 4.87e-06 | 205 | 157 | 10 | int:LRRC31 | |
| Interaction | SIRT7 interactions | CDK9 FLNB MYCBP2 SMCHD1 CANX GART RPS19 NCL MSH2 PGK1 TGM3 IARS2 FANCI AHNAK PES1 KMT2A NUP188 HERC2 CLUH | 5.58e-06 | 744 | 157 | 19 | int:SIRT7 |
| Interaction | OPTN interactions | HSPE1 ZNF384 MYO6 SMCHD1 TNIP1 NCL NCOA4 NEB CBS RAB10 GLO1 AFG3L2 PALS2 PICK1 | 5.79e-06 | 422 | 157 | 14 | int:OPTN |
| Interaction | H3-3A interactions | ZNF384 KDM5A SMCHD1 PARP2 ASH1L RPS19 NCL MSH2 PARP1 KMT2D BRCA1 FANCI ZBTB40 KMT2A CDYL BOD1L1 HERC2 ASB2 HELLS | 6.14e-06 | 749 | 157 | 19 | int:H3-3A |
| Interaction | CEBPB interactions | CDK9 HSPE1 ZNF384 FLNB VPS4A SMCHD1 CANX GART SPART RPS19 NCL MSH2 IRGQ PGK1 USP14 PARP1 GTF2H1 KMT2D BRCA1 BRCA2 ARHGEF1 AHNAK GLO1 PES1 DKC1 SMS CLUH HELLS | 6.27e-06 | 1443 | 157 | 28 | int:CEBPB |
| Interaction | NR3C1 interactions | UBR1 SMG1 ABCC1 ZNF536 MYO6 KDM5A SMCHD1 CANX MRPS35 NCL NCOA4 NEB RYR2 RAB10 PARP1 PARP4 KMT2D AAAS ACAD11 UBE3A NUP188 HELLS | 6.92e-06 | 974 | 157 | 22 | int:NR3C1 |
| Interaction | SEPTIN9 interactions | CDK9 FLNB MYO6 TNIP1 NCL MSH2 RAB10 PARP1 BRCA1 FANCI UQCRFS1 | 7.60e-06 | 265 | 157 | 11 | int:SEPTIN9 |
| Interaction | SLX4 interactions | ZNF384 SMCHD1 GART SPART NCL MSH2 TGM3 PARP1 ACAD11 BRCA1 BRCA2 FANCI PES1 NUP188 PC HELLS | 1.06e-05 | 572 | 157 | 16 | int:SLX4 |
| Interaction | H3-4 interactions | KDM5A PARP2 CEP290 TNIP1 NCL PARP1 ARHGEF1 AHNAK KMT2A CDYL TRPM1 HERC2 DMD TADA3 | 1.14e-05 | 448 | 157 | 14 | int:H3-4 |
| Interaction | RNF168 interactions | 1.16e-05 | 98 | 157 | 7 | int:RNF168 | |
| Interaction | WDR5 interactions | PDXDC1 HSPE1 ZNF384 ABCC1 FLNB KDM5A SMCHD1 CANX MRPS35 RPS19 NCL ITIH2 UGT1A1 PARP1 KMT2D BRCA1 UBE3A DKC1 KMT2A BOD1L1 ALDH4A1 TADA3 HELLS | 1.49e-05 | 1101 | 157 | 23 | int:WDR5 |
| Interaction | ATP4A interactions | 1.61e-05 | 103 | 157 | 7 | int:ATP4A | |
| Interaction | APEX1 interactions | ZNF384 ABCC1 ZNF536 MYO6 USP28 SMCHD1 CEP290 RAET1E NCL PARP1 THADA BRCA1 BRCA2 ASAH1 FANCI ARHGEF1 AGL AHNAK PES1 ARMCX6 DKC1 KMT2A CFAP74 SEC14L2 HELLS | 1.69e-05 | 1271 | 157 | 25 | int:APEX1 |
| Interaction | CIT interactions | CDK9 ZNF384 FLNB MYO6 USP28 VPS4A UGT1A7 SMCHD1 CANX GART ASH1L RNF213 RPS19 NCL RAB10 AAAS BRCA1 FANCI AHNAK PES1 DKC1 KMT2A CDYL BOD1L1 NUP188 GAPDHS RBM47 | 1.97e-05 | 1450 | 157 | 27 | int:CIT |
| Interaction | CFTR interactions | PDXDC1 HSPE1 FLNB TBC1D9B MYH13 MYO1A MYO6 USP28 VPS4A ZGRF1 GDAP2 CANX RPS19 NCL CLEC12A PGK1 ITIH2 RYR2 TGM3 PARP1 THADA UBE3A AHNAK GLO1 DLG1 DMD ALPG | 2.83e-05 | 1480 | 157 | 27 | int:CFTR |
| Interaction | GUCY1B1 interactions | 3.17e-05 | 47 | 157 | 5 | int:GUCY1B1 | |
| Interaction | CLEC16A interactions | SECISBP2L PDXDC1 MYCBP2 VPS4A SPART CBS PARP4 IARS2 AAAS BRCA2 FANCI AGL AFG3L2 UQCRFS1 HERC2 PC | 3.37e-05 | 629 | 157 | 16 | int:CLEC16A |
| Interaction | CBX4 interactions | 3.38e-05 | 205 | 157 | 9 | int:CBX4 | |
| Interaction | RBM45 interactions | 3.65e-05 | 207 | 157 | 9 | int:RBM45 | |
| Interaction | H2BC4 interactions | SECISBP2L SMCHD1 PARP2 TNIP1 NCL NEB PARP1 FANCI AFG3L2 KMT2A | 3.70e-05 | 259 | 157 | 10 | int:H2BC4 |
| Interaction | FLT3 interactions | INPP5D CANX RNF213 BRCA1 NUAK1 BRCA2 FANCI AFG3L2 KMT2A NUP188 HELLS | 4.11e-05 | 318 | 157 | 11 | int:FLT3 |
| Interaction | UBE2L3 interactions | 4.23e-05 | 211 | 157 | 9 | int:UBE2L3 | |
| Interaction | LMBR1L interactions | PDXDC1 ABCC1 TBC1D9B EVC2 MYO6 VPS4A CANX MSH2 USP14 RAB10 THADA AAAS SLC12A2 LRIG1 UBE3A FANCI ARHGEF1 PES1 NUP188 HELLS | 4.79e-05 | 946 | 157 | 20 | int:LMBR1L |
| Interaction | ZNF330 interactions | CDK9 ZNF384 ZNF536 SMCHD1 NCL PARP1 FANCI PES1 DKC1 KMT2A NUP188 PICK1 HELLS | 4.85e-05 | 446 | 157 | 13 | int:ZNF330 |
| Interaction | UBC interactions | HSPE1 FLNB MYO6 CANX RNF213 TNIP1 USP14 PARP1 GTF2H1 BRCA1 UBE3A AHNAK HERC2 | 4.85e-05 | 446 | 157 | 13 | int:UBC |
| Interaction | RAD21 interactions | CDK9 FLNB PARP2 RPS19 MSH2 PGK1 PARP1 CCM2 BRCA1 BRCA2 XIRP2 AFG3L2 | 4.92e-05 | 384 | 157 | 12 | int:RAD21 |
| Interaction | KCNA3 interactions | FLNB MYO6 CANX GART SPART RNF213 RPS19 MSH2 DENND4C RAB10 PARP1 FANCI AHNAK AFG3L2 KMT2A DLG1 BOD1L1 TRPM1 CAMSAP1 | 4.95e-05 | 871 | 157 | 19 | int:KCNA3 |
| Interaction | CTTN interactions | CDK9 FLNB MYCBP2 MYO6 GART TNIP1 RPS19 ARHGAP35 PARP1 BRCA2 UBE3A AHNAK CLUH | 5.32e-05 | 450 | 157 | 13 | int:CTTN |
| Interaction | CCDC8 interactions | FLNB MYCBP2 SMCHD1 CANX CEP290 GART RPS19 NCL MSH2 PARP1 SLC12A2 AHNAK AFG3L2 NUP188 HERC2 HELLS | 5.55e-05 | 656 | 157 | 16 | int:CCDC8 |
| Interaction | DERL1 interactions | ABCC1 TEX2 SMCHD1 CANX GART ATL1 USP14 PARP1 IARS2 AAAS SLC12A2 CAMSAP1 RBM47 | 5.69e-05 | 453 | 157 | 13 | int:DERL1 |
| Interaction | KCNJ12 interactions | 6.27e-05 | 28 | 157 | 4 | int:KCNJ12 | |
| Interaction | RPS24 interactions | CANX TNIP1 RPS19 NCL CCDC168 MSH2 PGK1 USP14 BRCA1 FANCI PES1 DKC1 NUP188 HERC2 | 7.01e-05 | 529 | 157 | 14 | int:RPS24 |
| Interaction | H1-5 interactions | ZNF536 PARP2 TNIP1 RPS19 NCL CCDC168 PARP1 XIRP2 WDR87 DNAH17 DKC1 TTLL1 HELLS | 7.09e-05 | 463 | 157 | 13 | int:H1-5 |
| Interaction | FASN interactions | CDK9 ABCC1 FLNB KDM5A TNIP1 RPS19 USP14 RAB10 UBE4A PARP1 AAAS BRCA1 NUAK1 PES1 ZBTB40 KMT2A SMS NUP188 MAML2 PC TADA3 | 7.97e-05 | 1062 | 157 | 21 | int:FASN |
| Interaction | NUMA1 interactions | CDK9 USP28 PARP2 TNIP1 PARP1 BRCA1 BRDT ARHGEF1 KMT2A CDYL SMS PALS2 HELLS | 8.07e-05 | 469 | 157 | 13 | int:NUMA1 |
| Interaction | PHF21A interactions | FLNB ZNF536 MYH13 MYCBP2 ZGRF1 TNIP1 DENND4C KMT2D BRCA2 AHNAK PC | 8.11e-05 | 343 | 157 | 11 | int:PHF21A |
| Interaction | CLSPN interactions | 8.34e-05 | 92 | 157 | 6 | int:CLSPN | |
| Interaction | RAD23B interactions | 8.51e-05 | 231 | 157 | 9 | int:RAD23B | |
| Interaction | C9orf72 interactions | CDK9 PDXDC1 ACP6 MYCBP2 MYO6 VPS4A CANX GART SPART RPS19 NCL MSH2 CBS PARP1 IARS2 AAAS UBE3A FANCI AGL PES1 AFG3L2 DKC1 NUP188 HELLS | 8.71e-05 | 1319 | 157 | 24 | int:C9orf72 |
| Interaction | BUB3 interactions | 8.80e-05 | 232 | 157 | 9 | int:BUB3 | |
| Interaction | MAPK6 interactions | ZNF775 MYCBP2 SPART NCOA4 AAAS NRXN2 BRCA2 UBE3A FANCI DKC1 SMS HERC2 CA1 | 8.98e-05 | 474 | 157 | 13 | int:MAPK6 |
| Interaction | RAN interactions | SECISBP2L CDK9 FLNB MYCBP2 ASH1L TNIP1 NCL USP14 BRCA1 AGL KMT2A NUP188 ASB2 | 9.17e-05 | 475 | 157 | 13 | int:RAN |
| Interaction | GAPDH interactions | CDK9 TIGD7 ZNF423 CEP290 GART TNIP1 NCL PGK1 USP14 UBE4A PARP1 LIPC BRCA1 SCN8A GAPDHS HERC2 | 9.37e-05 | 686 | 157 | 16 | int:GAPDH |
| Interaction | KLHDC4 interactions | 9.47e-05 | 31 | 157 | 4 | int:KLHDC4 | |
| Interaction | BIRC3 interactions | HSPE1 FLNB VPS4A SMCHD1 CANX GART MRPS35 RPS19 NCL MSH2 CBS PGK1 UBE4A TGM3 PARP1 IARS2 AAAS FANCI GLO1 PES1 DKC1 NUP188 PC CLUH | 1.04e-04 | 1334 | 157 | 24 | int:BIRC3 |
| Interaction | BRCA1 interactions | CDK9 UBR1 ABCC1 FLNB USP28 ZNF423 SMCHD1 GART RPS19 NCL MSH2 PGK1 PARP1 PARP4 AAAS BRCA1 BRCA2 UBE3A FANCI AGL AHNAK UQCRFS1 HERC2 | 1.04e-04 | 1249 | 157 | 23 | int:BRCA1 |
| Interaction | XRCC6 interactions | CDK9 SMCHD1 CANX PARP2 GART TNIP1 RPS19 NCL MSH2 USP14 PARP1 BRCA1 BRCA2 UBE3A KMT2A BOD1L1 TADA3 CLUH HELLS | 1.14e-04 | 928 | 157 | 19 | int:XRCC6 |
| Interaction | DMD interactions | 1.20e-04 | 141 | 157 | 7 | int:DMD | |
| Interaction | KIF2A interactions | 1.21e-04 | 242 | 157 | 9 | int:KIF2A | |
| Interaction | FLYWCH1 interactions | 1.22e-04 | 33 | 157 | 4 | int:FLYWCH1 | |
| Interaction | UGT1A9 interactions | 1.25e-04 | 13 | 157 | 3 | int:UGT1A9 | |
| Interaction | SERPINH1 interactions | 1.48e-04 | 306 | 157 | 10 | int:SERPINH1 | |
| Interaction | REV1 interactions | 1.54e-04 | 35 | 157 | 4 | int:REV1 | |
| Interaction | UGT1A5 interactions | 1.59e-04 | 14 | 157 | 3 | int:UGT1A5 | |
| Interaction | CCDC65 interactions | 1.59e-04 | 14 | 157 | 3 | int:CCDC65 | |
| Interaction | MAPT interactions | MYO6 GART RPS19 NCL MSH2 PGK1 ITIH2 ATL1 USP14 RAB10 PARP1 AAAS SLC12A2 BRCA1 AGL AHNAK AFG3L2 DLG1 BOD1L1 ALDH4A1 UQCRFS1 | 1.65e-04 | 1119 | 157 | 21 | int:MAPT |
| Interaction | FLNA interactions | CDK9 FLNB UAP1 MYO6 ZGRF1 GART TNIP1 NCL GRM7 USP14 BRCA1 BRCA2 AHNAK ASB2 CLUH | 1.70e-04 | 648 | 157 | 15 | int:FLNA |
| Interaction | PMS1 interactions | 1.73e-04 | 105 | 157 | 6 | int:PMS1 | |
| Interaction | UGT1A8 interactions | 1.80e-04 | 3 | 157 | 2 | int:UGT1A8 | |
| Interaction | HSPA9 interactions | CDK9 HSPE1 FLNB MYCBP2 CANX SPART MRPS35 TNIP1 NCL PGK1 IARS2 BRCA1 AHNAK AFG3L2 UQCRFS1 CLUH | 1.82e-04 | 727 | 157 | 16 | int:HSPA9 |
| Interaction | CENPA interactions | CDK9 ZNF384 ZNF536 SMCHD1 PARP2 PGK1 PARP1 PES1 KMT2A NUP188 HELLS | 1.86e-04 | 377 | 157 | 11 | int:CENPA |
| Interaction | PRKCSH interactions | 1.90e-04 | 257 | 157 | 9 | int:PRKCSH | |
| Interaction | PER2 interactions | 2.00e-04 | 153 | 157 | 7 | int:PER2 | |
| Interaction | SUMO2 interactions | HSPE1 FLNB SPR USP28 SMCHD1 RNF213 TNIP1 NCL MSH2 PGK1 PARP1 BRCA1 AHNAK BOD1L1 | 2.23e-04 | 591 | 157 | 14 | int:SUMO2 |
| Interaction | H2AX interactions | CDK9 PARP2 MRPS35 NCL MSH2 NEB PGK1 USP14 UBE4A PARP1 BRCA1 BRCA2 DKC1 CDYL | 2.30e-04 | 593 | 157 | 14 | int:H2AX |
| Interaction | CEBPA interactions | CDK9 ZNF384 MYCBP2 SPR INPP5D SMCHD1 MSH2 PGK1 USP14 RAB10 PARP1 KMT2D BRCA1 UBE3A FANCI GLO1 PES1 ZBTB40 KMT2A SMS TADA3 HELLS | 2.66e-04 | 1245 | 157 | 22 | int:CEBPA |
| Interaction | AR interactions | CDK9 MYCBP2 MYO6 USP28 SMCHD1 RNF213 NCOA4 PGK1 USP14 RAB10 PARP1 GTF2H1 KMT2D AAAS BRCA1 UBE3A KMT2A NUP188 TADA3 | 2.68e-04 | 992 | 157 | 19 | int:AR |
| Interaction | TOP3A interactions | 2.71e-04 | 114 | 157 | 6 | int:TOP3A | |
| Interaction | FMR1 interactions | SMG1 MYCBP2 KDM5A USP28 TNIP1 NCL USP14 PLPPR4 AHNAK DKC1 DLG1 HERC2 PICK1 | 2.99e-04 | 536 | 157 | 13 | int:FMR1 |
| Interaction | SQSTM1 interactions | CDK9 SMG1 ZNF384 FLNB MYO6 CEP290 GART SPART TNIP1 RPS19 ARHGAP35 NCOA4 USP14 RAB10 PARP1 IARS2 AAAS BRCA1 ARHGEF1 AHNAK NUP188 SNTB1 | 3.04e-04 | 1257 | 157 | 22 | int:SQSTM1 |
| Interaction | QDPR interactions | 3.15e-04 | 42 | 157 | 4 | int:QDPR | |
| Interaction | CHMP4C interactions | FLNB VPS4A CANX GART RNF213 RPS19 NCL PGK1 PARP1 IARS2 AAAS WDR87 AHNAK DKC1 GAPDHS | 3.17e-04 | 687 | 157 | 15 | int:CHMP4C |
| Interaction | PPP1CB interactions | FLNB MYCBP2 MYO6 GART RNF213 TNIP1 NCL RYR2 PARP1 BRCA1 NUAK1 SMS | 3.18e-04 | 469 | 157 | 12 | int:PPP1CB |
| Interaction | EED interactions | PDXDC1 COL4A2 FLNB TBC1D9B MYCBP2 MYO6 KDM5A SMCHD1 CEP290 GART NCL MSH2 PGK1 USP14 PARP1 THADA BRCA1 XIRP2 PES1 DKC1 NUP188 HERC2 CLUH HELLS | 3.43e-04 | 1445 | 157 | 24 | int:EED |
| Interaction | CDK8 interactions | 3.58e-04 | 222 | 157 | 8 | int:CDK8 | |
| Interaction | APTX interactions | 3.59e-04 | 78 | 157 | 5 | int:APTX | |
| Interaction | SWAP70 interactions | 3.59e-04 | 78 | 157 | 5 | int:SWAP70 | |
| Interaction | SMTN interactions | 3.78e-04 | 44 | 157 | 4 | int:SMTN | |
| Interaction | SETD1A interactions | 3.79e-04 | 170 | 157 | 7 | int:SETD1A | |
| Interaction | HDAC1 interactions | FLNB ZNF536 MYCBP2 KDM5A ZGRF1 ZNF423 PARP2 TNIP1 RPS19 DENND4C PARP1 KMT2D BRCA1 BRCA2 AHNAK KMT2A CDYL CAMSAP1 PC HELLS | 3.95e-04 | 1108 | 157 | 20 | int:HDAC1 |
| Interaction | MDC1 interactions | FLNB USP28 SMCHD1 TNIP1 NCL USP14 BRCA1 BRCA2 AFG3L2 BOD1L1 HERC2 | 4.13e-04 | 414 | 157 | 11 | int:MDC1 |
| Interaction | ERCC2 interactions | 4.28e-04 | 81 | 157 | 5 | int:ERCC2 | |
| Interaction | ERCC4 interactions | 4.28e-04 | 81 | 157 | 5 | int:ERCC4 | |
| Interaction | TRIM28 interactions | CDK9 MYCBP2 MYO6 PARP2 MRPS35 TNIP1 NCL MSH2 CBS USP14 PARP1 IARS2 AAAS BRCA1 BRCA2 UBE3A AGL PES1 ZNF808 ALDH4A1 SMS NUP188 PC RSL24D1 | 4.57e-04 | 1474 | 157 | 24 | int:TRIM28 |
| Interaction | H1-3 interactions | 4.74e-04 | 291 | 157 | 9 | int:H1-3 | |
| Interaction | H2AC17 interactions | 4.80e-04 | 232 | 157 | 8 | int:H2AC17 | |
| Interaction | DNAJC7 interactions | IFT140 EVC2 TEX2 GART USP14 UBE4A IARS2 BRCA2 AFG3L2 HERC2 CLUH | 5.14e-04 | 425 | 157 | 11 | int:DNAJC7 |
| Interaction | H3C3 interactions | ZNF384 KDM5A SMCHD1 MSH2 PARP1 BRCA1 FANCI PES1 KMT2A CDYL BOD1L1 HELLS | 5.14e-04 | 495 | 157 | 12 | int:H3C3 |
| Interaction | DNAJC9 interactions | 5.35e-04 | 296 | 157 | 9 | int:DNAJC9 | |
| Interaction | USP7 interactions | ZNF536 MYH13 USP28 ZGRF1 ZNF423 TNIP1 NCL NEB USP14 PARP1 KMT2D TENM4 BRCA1 AHNAK PES1 ARMCX6 TRPM1 UQCRFS1 DMD CAMSAP1 PC PICK1 | 5.51e-04 | 1313 | 157 | 22 | int:USP7 |
| Interaction | BAP1 interactions | HSPE1 FLNB MYCBP2 MYO6 USP28 VPS4A CANX GART SPART MRPS35 RPS19 NCL PGK1 RAB10 PARP1 BRCA1 BRCA2 FANCI AGL AHNAK GLO1 SMS | 5.56e-04 | 1314 | 157 | 22 | int:BAP1 |
| Interaction | SPZ1 interactions | 5.56e-04 | 21 | 157 | 3 | int:SPZ1 | |
| Interaction | MKI67 interactions | HSPE1 SMG1 ZNF384 TNIP1 PARP1 KMT2D BRCA1 NUAK1 BRCA2 ARHGEF1 PES1 KMT2A DNMBP RSL24D1 | 5.60e-04 | 648 | 157 | 14 | int:MKI67 |
| Interaction | GRIA1 interactions | 5.64e-04 | 86 | 157 | 5 | int:GRIA1 | |
| Interaction | CKMT2 interactions | 5.64e-04 | 86 | 157 | 5 | int:CKMT2 | |
| Cytoband | 2q37 | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 ALPG | 8.82e-18 | 31 | 161 | 10 | 2q37 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q37 | UGT1A10 UGT1A8 UGT1A7 UGT1A6 INPP5D UGT1A5 UGT1A9 NCL UGT1A4 UGT1A1 UGT1A3 ALPG | 3.30e-11 | 226 | 161 | 12 | chr2q37 |
| Cytoband | 12p11 | 4.33e-04 | 9 | 161 | 2 | 12p11 | |
| Cytoband | 15q13 | 4.33e-04 | 9 | 161 | 2 | 15q13 | |
| GeneFamily | UDP glucuronosyltransferases | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 2.84e-13 | 32 | 114 | 9 | 363 |
| GeneFamily | Zinc fingers|Zinc fingers PARP-type|Poly(ADP-ribose) polymerases | 1.56e-04 | 17 | 114 | 3 | 684 | |
| GeneFamily | Ring finger proteins|Fanconi anemia complementation groups|Protein phosphatase 1 regulatory subunits|BRCA1 A complex|BRCA1 B complex|BRCA1 C complex | 2.57e-04 | 20 | 114 | 3 | 548 | |
| GeneFamily | Classical BAR domain containing | 1.08e-03 | 8 | 114 | 2 | 1292 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 1.27e-03 | 34 | 114 | 3 | 487 | |
| GeneFamily | PHD finger proteins | 2.53e-03 | 90 | 114 | 4 | 88 | |
| GeneFamily | PDZ domain containing | 2.77e-03 | 152 | 114 | 5 | 1220 | |
| Coexpression | GSE28783_CTRL_ANTI_MIR_VS_UNTREATED_ATHEROSCLEROSIS_MACROPHAGE_UP | 4.30e-07 | 199 | 160 | 10 | M8354 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | SECISBP2L ABCC1 FLNB MYCBP2 KDM5A SMCHD1 SPART MSH2 ARHGAP35 BRCA1 LRIG1 NUAK1 BRCA2 UBE3A DLG1 CDYL DMD PALS2 DNMBP | 1.29e-06 | 856 | 160 | 19 | M4500 |
| Coexpression | GSE22886_NAIVE_BCELL_VS_NEUTROPHIL_UP | 3.92e-06 | 199 | 160 | 9 | M4481 | |
| Coexpression | NFE2L2.V2 | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 SPART UGT1A9 CBS UGT1A4 UGT1A1 UGT1A3 WDR87 DMD | 6.60e-06 | 469 | 160 | 13 | M2870 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | MYCBP2 MYO6 SMCHD1 CEP290 NCL MSH2 JAKMIP2 ATL1 BRCA1 UBE3A ASAH1 SMS TRPM1 CTSV HELLS | 1.27e-05 | 656 | 160 | 15 | M18979 |
| Coexpression | GSE3982_NKCELL_VS_TH1_DN | 3.31e-05 | 200 | 160 | 8 | M5595 | |
| Coexpression | GSE35685_CD34POS_CD10NEG_CD62LPOS_VS_CD34POS_CD10POS_BONE_MARROW_UP | 3.31e-05 | 200 | 160 | 8 | M9080 | |
| Coexpression | FEVR_CTNNB1_TARGETS_DN | PECR ZGRF1 GART NCL MSH2 NCOA4 USP14 SLC12A2 BRCA1 LRIG1 BRCA2 DMD HELLS | 3.85e-05 | 555 | 160 | 13 | M2343 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | SMG1 ZNF536 KDM5A ZGRF1 ZNF423 SMCHD1 CANX PARP2 MSH2 ARHGAP35 JAKMIP2 RAB10 UBE4A SLC12A2 NRXN2 DLG1 CFAP74 BOD1L1 | 4.09e-07 | 595 | 156 | 18 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_1000 | PECR TEX2 USP28 ZGRF1 RNF213 MSH2 PARP1 THADA AAAS BRCA1 BRCA2 BRDT FANCI DKC1 SMS NUP188 RBM47 HELLS | 3.55e-05 | 822 | 156 | 18 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_1000 |
| ToppCell | mild-CD8+_Tem|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.78e-08 | 200 | 160 | 9 | d8aec4904c9420b8f9d7508658ba1e36c66cdfcc | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.78e-08 | 200 | 160 | 9 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | droplet-Lung-1m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.11e-07 | 181 | 160 | 8 | 136b0c60680068838d184d32aa99d7bea8718dbc | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 3.83e-07 | 186 | 160 | 8 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 4.68e-07 | 191 | 160 | 8 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 4.87e-07 | 192 | 160 | 8 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Epithelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.01e-06 | 172 | 160 | 7 | feaaf8ca7983d04a59ed0a7b3fb0e6d4b3a055f2 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.01e-06 | 172 | 160 | 7 | 9adfb4a65669cc536343616637058d0a4728013f | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.01e-06 | 172 | 160 | 7 | 8aed9c113f27d00401c272a3684495a4bc75bd0f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.64e-06 | 177 | 160 | 7 | da8802a6351d3e510822f82e2fde8a4314a2216e | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 4.22e-06 | 181 | 160 | 7 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-Lgr5+_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.70e-06 | 184 | 160 | 7 | e7b9c69fc77040c5191ad8089697051e2589c30e | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 4.87e-06 | 185 | 160 | 7 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 5.04e-06 | 186 | 160 | 7 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Myeloid-Cd4_positive_Macrophages|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.00e-06 | 191 | 160 | 7 | 45023854f285ac465f23ea1b33c970e14992e709 | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.00e-06 | 191 | 160 | 7 | 6890a8e4b4530987a5b044614fcd7e00716a4d66 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.43e-06 | 193 | 160 | 7 | be28070c049e7cb68bcd54f582226eb2f5e4bc1c | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.43e-06 | 193 | 160 | 7 | 0c652ebe22ce5d2927599dd97ef1920547858395 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.43e-06 | 193 | 160 | 7 | 8689a70a33a7c3823dc647d41ac0160e7c3ae396 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 6.65e-06 | 194 | 160 | 7 | 590a9d4f054e6a3685daf752c9354650fcc7d18a | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4|GI_small-bowel / Manually curated celltypes from each tissue | 6.65e-06 | 194 | 160 | 7 | 4547b57669be5d4f0de55175802ee04372288a6a | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Mesenchymal-Mesoderm|3m / Sample Type, Dataset, Time_group, and Cell type. | 8.11e-06 | 200 | 160 | 7 | 538ae964db58c4acafe93f735b3e03fc08fdaac6 | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 8.11e-06 | 200 | 160 | 7 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | LA-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 1.12e-05 | 139 | 160 | 6 | 9e2a84d5ed7232b70eadbba754d9ca13f2d50fe9 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.54e-05 | 147 | 160 | 6 | 94998bc40f5c08295cfe3bdcbe43f13b1e564b3d | |
| ToppCell | LA-15._Ventricular_Cardiomyocyte_III|LA / Chamber and Cluster_Paper | 1.54e-05 | 147 | 160 | 6 | 8970eb6b82589f39439c61a57d999661ec8342de | |
| ToppCell | droplet-Liver-Npc-18m-Epithelial-Hepatocyte_(Midlobular)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-05 | 151 | 160 | 6 | 86efabf27c264c856dca1cffacb16cef52e9863c | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 2.15e-05 | 156 | 160 | 6 | 1545169694f686d28648a68b552c2ae606599d66 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 2.40e-05 | 159 | 160 | 6 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | droplet-Liver-Hepatocytes-21m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.85e-05 | 164 | 160 | 6 | c9866a289e120be4066e66275c3beb97ba67cca4 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.38e-05 | 169 | 160 | 6 | 121768fc51fc3441ec725346a1bbe29e21d05971 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c07-AHNAK|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.61e-05 | 171 | 160 | 6 | 7b0783d25055e5ea5b2fc44ebcb16bfd0adbcf81 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_B-GC_B_(I)|bone_marrow / Manually curated celltypes from each tissue | 3.85e-05 | 173 | 160 | 6 | 67f0f0bf88eab69987b71d96b864ed2b14975adb | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.24e-05 | 176 | 160 | 6 | 327a3e81b724252e36d786de92a3ffd721ea6d7b | |
| ToppCell | 390C-Endothelial_cells-Endothelial-E-|390C / Donor, Lineage, Cell class and subclass (all cells) | 4.51e-05 | 178 | 160 | 6 | 804ac3725c1f88e2212172bfb9aa01d97a735621 | |
| ToppCell | 390C-Endothelial_cells-Endothelial-E|390C / Donor, Lineage, Cell class and subclass (all cells) | 4.51e-05 | 178 | 160 | 6 | ad6dc4a375664c919bd48c35c48a561fc5a7de8c | |
| ToppCell | facs-Large_Intestine-Proximal-18m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.95e-05 | 181 | 160 | 6 | 9fce5eee75684a7ecac6996e26e9215bc95098b2 | |
| ToppCell | facs-Large_Intestine-Proximal-18m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.95e-05 | 181 | 160 | 6 | ad97e802e934738ddece675232a72308db2da256 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.95e-05 | 181 | 160 | 6 | 071f9bb5d39070cdc473d9b0e094d196bc702b56 | |
| ToppCell | COVID-19-Heart-CM_3|Heart / Disease (COVID-19 only), tissue and cell type | 5.11e-05 | 182 | 160 | 6 | 287fcc3897ae08841f6f85ae6c9cef16f75b1dd1 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.11e-05 | 182 | 160 | 6 | ed6ae0fd8653f213fe29906a6a4e0729a62e1b75 | |
| ToppCell | LA-11._Adipocyte|LA / Chamber and Cluster_Paper | 5.26e-05 | 183 | 160 | 6 | 3f9011976782fa8aa95cdd6f00f07a91094d411b | |
| ToppCell | facs-Liver-Hepatocytes-24m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.26e-05 | 183 | 160 | 6 | d0721c6aa426953a520d40e976b6e65aa7ca65e8 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.26e-05 | 183 | 160 | 6 | 92fbd83a9d13ee91065cbd479fb298f1fd564568 | |
| ToppCell | droplet-Lung-30m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.26e-05 | 183 | 160 | 6 | 351d575339038bd4a66f408da518c567444208e8 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.76e-05 | 186 | 160 | 6 | 15ab6666748a641226e42e6ca6eeaf186a501c95 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.76e-05 | 186 | 160 | 6 | 4ed1b97e2552f3c4134f25665d7513498ffac16c | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 5.93e-05 | 187 | 160 | 6 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | RA-11._Adipocyte|World / Chamber and Cluster_Paper | 6.11e-05 | 188 | 160 | 6 | 4dac9d636e5cad4cda540b93d4bfed6b5732c880 | |
| ToppCell | Control|World / Disease Group and Platelet Clusters | 6.11e-05 | 188 | 160 | 6 | f07654b215279abaf1c0882cdf41fbe31580a2ca | |
| ToppCell | mild-Myeloid-Immature_Neutrophils_1|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 6.29e-05 | 189 | 160 | 6 | 94dd5d4d815449feff7ce157fe7f8234f7c81422 | |
| ToppCell | HSPCs-Gran/Mono_prog.|World / Lineage and Cell class | 6.48e-05 | 190 | 160 | 6 | 94547c1cc2c3f2ac28a6d07317e50e1e3fd20267 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-intestinal_crypt_stem_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.48e-05 | 190 | 160 | 6 | 52c59001a079c76249abbaa3141e9e661b83d9a0 | |
| ToppCell | pdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 6.48e-05 | 190 | 160 | 6 | d06ee5f89f1cec8db6897fe3b2a890a07cd3697b | |
| ToppCell | droplet-Large_Intestine-COLON:P+D-30m-Epithelial-intestinal_crypt_stem_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.87e-05 | 192 | 160 | 6 | 448b71c965e1b7addc6bccbcd6047cefda3d5b5a | |
| ToppCell | droplet-Large_Intestine-COLON:P+D-30m-Epithelial-Lgr5+_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.87e-05 | 192 | 160 | 6 | 5155f746ad57122ef735da776c96721005b8dadc | |
| ToppCell | facs-Heart-RV-18m-Myeloid-macrophage|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.07e-05 | 193 | 160 | 6 | 77bc4353a1e9eae32bc6beb333577ba0294a10fc | |
| ToppCell | facs-Heart-RV-18m-Myeloid-macrophage|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.07e-05 | 193 | 160 | 6 | b9b431c18c81c616069a546cded4753563a1e701 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.07e-05 | 193 | 160 | 6 | 000b9e6a819b94ea2e6e9173daf97ba9ac2b6cc6 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.07e-05 | 193 | 160 | 6 | 0f2167eef8203a5659c8c72e4e77646003d64797 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 7.07e-05 | 193 | 160 | 6 | bbdfda6665941cfa1965418bb91ef9ff43b1326f | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 7.07e-05 | 193 | 160 | 6 | 4b9fa2a4424f8abe63fa7bee78db93dda04ab15f | |
| ToppCell | human_hepatoblastoma-Tumor_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 7.07e-05 | 193 | 160 | 6 | 503a979328c68b096680b71359a26f02fafdff35 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 7.07e-05 | 193 | 160 | 6 | 516ea2c12bdc7a5dc676159d627e36f6abe13ef0 | |
| ToppCell | 3'_v3-blood-Lymphocytic_NK-Cycling_NK|blood / Manually curated celltypes from each tissue | 7.27e-05 | 194 | 160 | 6 | bf9734abaad603ade2a6a6940918aaf1e1c4e2cd | |
| ToppCell | tumor_Lung-T/NK_cells-Treg|T/NK_cells / Location, Cell class and cell subclass | 7.48e-05 | 195 | 160 | 6 | dd112ef3f8bd0790719827b6bb120918687afdff | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 7.48e-05 | 195 | 160 | 6 | cec7df321f372d05c94f97d6bb18891a5cc3dec3 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.48e-05 | 195 | 160 | 6 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.48e-05 | 195 | 160 | 6 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.69e-05 | 196 | 160 | 6 | df366d76ea55f49e349d622effa57c1535df8400 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 7.91e-05 | 197 | 160 | 6 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | Endothelial-Endothelial-A|Endothelial / shred on cell class and cell subclass (v4) | 7.92e-05 | 122 | 160 | 5 | 65849d1296934d5765afd006cbb6739383b9f49f | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_NK-Cycling_NK|lymph-node_spleen / Manually curated celltypes from each tissue | 8.14e-05 | 198 | 160 | 6 | b2868a897dd96494cf1829c30e0ce508f52efdf3 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_myocytic-stroma-muscle_stem_cell|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 8.14e-05 | 198 | 160 | 6 | 55e583321f60c95898d93cd0d2615c6692db52ec | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.14e-05 | 198 | 160 | 6 | 2e2a4e1756bba6f4fbe529559a97d2993c890b4b | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_basal-Dividing_Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.14e-05 | 198 | 160 | 6 | d5e125f0c4f41b47d567568d0838adcca7655f6d | |
| ToppCell | Transverse-T_cell-cycling_gd_T|T_cell / Region, Cell class and subclass | 8.36e-05 | 199 | 160 | 6 | 7cfe9b2538ea008d67343f3e8bfec3bf81200de6 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW12-OPC_related-OPC|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 8.36e-05 | 199 | 160 | 6 | c0dc14fb9899d4263264347436de121814441dfb | |
| ToppCell | 3'-Child04-06-SmallIntestine-Hematopoietic-B_cells-Cycling_B_cell|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.36e-05 | 199 | 160 | 6 | 8b7f84a1e385c6a9bd45a5d41f75e30819dbe32d | |
| ToppCell | COVID-19_Severe-immature_Neutrophil|COVID-19_Severe / Disease condition and Cell class | 8.36e-05 | 199 | 160 | 6 | f82fa9d651e78f9ebbe6264e00a48c54b1786a69 | |
| ToppCell | COVID-19_Severe-immature_Neutrophil-|COVID-19_Severe / Disease condition and Cell class | 8.36e-05 | 199 | 160 | 6 | 42ea0c19c455bdb0ae89b428d09c333104c670dc | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW12-OPC_related|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 8.36e-05 | 199 | 160 | 6 | 9bc53ff93ca97af4ee0f01c74a567987a26abb18 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 8.60e-05 | 200 | 160 | 6 | 72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 8.60e-05 | 200 | 160 | 6 | 032df80aa5c40991e1c1e80f9d8da106e6aeaee2 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Alv_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 8.60e-05 | 200 | 160 | 6 | edb64556b3fefe3144f73b6efe23b9ffd34091d2 | |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 8.60e-05 | 200 | 160 | 6 | 5c092b2ecc081b5d04476c56333c338cd89ab984 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN---|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 8.60e-05 | 200 | 160 | 6 | 68fce28690246895fd33354b30960ebcc31aa4cc | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN-|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 8.60e-05 | 200 | 160 | 6 | 376b19ab5a7cd2c85f726d8ba41337d4525863e5 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 8.60e-05 | 200 | 160 | 6 | 79e51afb57ca38aacebd0298e5e727b55c0cfff9 | |
| ToppCell | mild-gd_T|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.60e-05 | 200 | 160 | 6 | 109f673a4967ffa52270a0b4f818b3461288db44 | |
| ToppCell | VE|World / Condition, Cell_class and T cell subcluster | 8.60e-05 | 200 | 160 | 6 | 8ae7cb81de3ffac5acdf3466d4b516d80cac95d3 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 8.60e-05 | 200 | 160 | 6 | a1fa6bae5a688faf488d6925cd3fad725dfa916b | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN--|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 8.60e-05 | 200 | 160 | 6 | 7fa54370221ed61bac0e09e6bcf1f3dff202a846 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 8.60e-05 | 200 | 160 | 6 | d01cec331be3b03cef80e9536fc531285bcf00f6 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.60e-05 | 200 | 160 | 6 | af3dc76b4507bf4edd265169f5dfbbb8a19eb394 | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-gd_T|COVID-19_Severe / Disease, condition lineage and cell class | 8.60e-05 | 200 | 160 | 6 | f72bc3f6606ae77fe1b0a972e35b3ce0727804d9 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN----L2-6|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 8.60e-05 | 200 | 160 | 6 | 878bbbe32e3602723aa14ef32877ab2453b8c6e5 | |
| ToppCell | Hematolymphoid-Endothelial|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 8.60e-05 | 200 | 160 | 6 | 7136936d05ab344a560cf159684c881063b5430d | |
| ToppCell | TCGA-Peripheral_Nervous_System-Primary_Tumor-Paraganglioma-Paraganglioma-3|TCGA-Peripheral_Nervous_System / Sample_Type by Project: Shred V9 | 1.28e-04 | 135 | 160 | 5 | ac20133d4a36f48338b45bffb13e842cb66f83ad | |
| ToppCell | 356C-Fibroblasts-Fibroblast-E|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.32e-04 | 136 | 160 | 5 | edfd453c9a650d69d05a5a3ab15f7df56349fa86 | |
| Drug | AC1MRQNQ | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 3.33e-20 | 9 | 160 | 9 | CID003522271 |
| Drug | DHPASiU | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 3.33e-20 | 9 | 160 | 9 | CID000197602 |
| Drug | 3-iodophenol | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 3.33e-20 | 9 | 160 | 9 | CID000012272 |
| Drug | AC1L4J7U | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 3.33e-20 | 9 | 160 | 9 | CID000186631 |
| Drug | Chebi:32663 | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 3.33e-20 | 9 | 160 | 9 | CID005460873 |
| Drug | 2,2',3,5,5'-pentachlorobiphenyl | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 CBS UGT1A4 UGT1A1 UGT1A3 | 6.44e-19 | 15 | 160 | 10 | CID000040469 |
| Drug | 4-nitrophenyl)imidazole | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.81e-18 | 11 | 160 | 9 | CID000123155 |
| Drug | AC1O5XMV | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.81e-18 | 11 | 160 | 9 | CID006442661 |
| Drug | N-OH-DABZ | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 7.19e-18 | 12 | 160 | 9 | CID000051366 |
| Drug | 1-O-beta-D-glucopyranosyl-D-mannitol | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 7.19e-18 | 12 | 160 | 9 | CID000088735 |
| Drug | 2,4,6-TCB | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 7.19e-18 | 12 | 160 | 9 | CID000037247 |
| Drug | nonanoyl-N-methylglucamide | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 7.19e-18 | 12 | 160 | 9 | CID000160090 |
| Drug | 7,7,7-triphenylheptanoic acid | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 7.19e-18 | 12 | 160 | 9 | CID000276709 |
| Drug | tritanol | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 2.32e-17 | 13 | 160 | 9 | CID000006457 |
| Drug | 5-azido-UDP-glucuronic acid | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 2.32e-17 | 13 | 160 | 9 | CID003081279 |
| Drug | cotinine-N-glucuronide | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 2.32e-17 | 13 | 160 | 9 | CID000000411 |
| Drug | propranolol glucuronide | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 6.47e-17 | 14 | 160 | 9 | CID000119515 |
| Drug | PCB-61 | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 6.47e-17 | 14 | 160 | 9 | CID000036401 |
| Drug | afloqualone | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.61e-16 | 15 | 160 | 9 | CID000002040 |
| Drug | naphthyl sulphate | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.61e-16 | 15 | 160 | 9 | CID000114775 |
| Drug | coumarin-3-carboxylic acid | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.61e-16 | 15 | 160 | 9 | CID000010752 |
| Drug | sulforaphane nitrile | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.61e-16 | 15 | 160 | 9 | CID000543743 |
| Drug | amidoxime | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 PARP1 | 2.34e-16 | 23 | 160 | 10 | CID000465967 |
| Drug | quercetin-3,4'-diglucoside | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 3.65e-16 | 16 | 160 | 9 | CID005320835 |
| Drug | 1'-hydroxyestragole | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 3.65e-16 | 16 | 160 | 9 | CID000040003 |
| Drug | bilirubin-phosphate | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 3.65e-16 | 16 | 160 | 9 | CID005497144 |
| Drug | 3 beta,5 alpha,25R)- 3-hydroxyspirostan-12-one | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 7.71e-16 | 17 | 160 | 9 | CID000003573 |
| Drug | 6-hydroxychrysene | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 7.71e-16 | 17 | 160 | 9 | CID000037766 |
| Drug | SureCN12722713 | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.53e-15 | 18 | 160 | 9 | CID005488034 |
| Drug | ethyl-beta-D-6-glucosiduronic acid | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.53e-15 | 18 | 160 | 9 | CID000152226 |
| Drug | Br 2 | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.53e-15 | 18 | 160 | 9 | CID003060900 |
| Drug | 2,3,7-trichlorodibenzo-p-dioxin | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.53e-15 | 18 | 160 | 9 | CID000036614 |
| Drug | ApApG | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.53e-15 | 18 | 160 | 9 | CID003081975 |
| Drug | C1 11-32 | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.53e-15 | 18 | 160 | 9 | CID000443077 |
| Drug | C11131 | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.53e-15 | 18 | 160 | 9 | CID000443076 |
| Drug | CARMINE | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 SLC12A2 | 2.60e-15 | 28 | 160 | 10 | CID000014749 |
| Drug | N-hydroxy-4-aminobiphenyl | MYO6 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 2.60e-15 | 28 | 160 | 10 | CID000081261 |
| Drug | H-Ni | ABCC1 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 2.60e-15 | 28 | 160 | 10 | CID000445665 |
| Drug | 9-OH-risperidone | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 2.90e-15 | 19 | 160 | 9 | CID000475100 |
| Drug | 5alpha-spirostan-3beta-ol | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 2.90e-15 | 19 | 160 | 9 | CID000091433 |
| Drug | almokalant | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 2.90e-15 | 19 | 160 | 9 | CID003033962 |
| Drug | iberin | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 PARP1 | 3.95e-15 | 29 | 160 | 10 | CID000010455 |
| Drug | tectochrysin | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 5.24e-15 | 20 | 160 | 9 | CID005281954 |
| Drug | AC1L1OBF | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 5.24e-15 | 20 | 160 | 9 | CID000032736 |
| Drug | 4'-hydroxydiclofenac | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 5.24e-15 | 20 | 160 | 9 | CID000116545 |
| Drug | AC1L9E0Q | ABCC1 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 5.89e-15 | 30 | 160 | 10 | CID000443095 |
| Drug | dihydroartemisinin | CDK9 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 5.89e-15 | 30 | 160 | 10 | CID000107770 |
| Drug | PCB 156 | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 CBS UGT1A4 UGT1A1 UGT1A3 | 8.64e-15 | 31 | 160 | 10 | CID000038019 |
| Drug | estriol-16-glucuronide | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 9.11e-15 | 21 | 160 | 9 | CID000122281 |
| Drug | dulcin | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 9.11e-15 | 21 | 160 | 9 | CID000009013 |
| Drug | Benzamidoxime hydrochloride | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 9.11e-15 | 21 | 160 | 9 | CID000069186 |
| Drug | indole-2-carboxylic acid | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 CBS UGT1A4 UGT1A1 UGT1A3 | 1.25e-14 | 32 | 160 | 10 | CID000072899 |
| Drug | NNAL | ABCC1 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.25e-14 | 32 | 160 | 10 | CID000104856 |
| Drug | amonafide | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.53e-14 | 22 | 160 | 9 | CID000050515 |
| Drug | N-methylpiperazine | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.53e-14 | 22 | 160 | 9 | CID000053167 |
| Drug | estradiol-3-glucuronide | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 2.50e-14 | 23 | 160 | 9 | CID000066651 |
| Drug | phenanthridine | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 2.50e-14 | 23 | 160 | 9 | CID000009189 |
| Drug | AS-3201 | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 3.98e-14 | 24 | 160 | 9 | CID000153948 |
| Drug | anisole | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 TNIP1 UGT1A4 UGT1A1 UGT1A3 | 4.80e-14 | 36 | 160 | 10 | CID000007519 |
| Drug | 5-MOP | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 6.18e-14 | 25 | 160 | 9 | CID000002355 |
| Drug | AzMC | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 6.18e-14 | 25 | 160 | 9 | CID000064986 |
| Drug | N-acetylbenzidine | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 6.18e-14 | 25 | 160 | 9 | CID000018787 |
| Drug | 5,6-benzoquinoline | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 6.18e-14 | 25 | 160 | 9 | CID000006796 |
| Drug | N-phenylmaleimide | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 6.18e-14 | 25 | 160 | 9 | CID000013662 |
| Drug | 4-methylumbelliferyl glucuronide | ABCC1 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 8.83e-14 | 38 | 160 | 10 | CID000091553 |
| Drug | x Me | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 BRCA2 | 8.83e-14 | 38 | 160 | 10 | CID009600424 |
| Drug | acacetin | ABCC1 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 8.83e-14 | 38 | 160 | 10 | CID005280442 |
| Drug | diflunisal | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.40e-13 | 27 | 160 | 9 | CID000003059 |
| Drug | DiMeIQx | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.40e-13 | 27 | 160 | 9 | CID000104739 |
| Drug | harmol | ABCC1 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.56e-13 | 40 | 160 | 10 | CID000068094 |
| Drug | erucin | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 2.05e-13 | 28 | 160 | 9 | CID000078160 |
| Drug | L 654969 | CDK9 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 2.68e-13 | 42 | 160 | 10 | CID000005218 |
| Drug | AC1L1JAL | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 2.96e-13 | 29 | 160 | 9 | CID000004954 |
| Drug | 7-hydroxycoumarin glucuronide | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 2.96e-13 | 29 | 160 | 9 | CID000125641 |
| Drug | 7-hydroxy-4-trifluoromethylcoumarin | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 2.96e-13 | 29 | 160 | 9 | CID005375667 |
| Drug | trans-3'-hydroxycotinine | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 2.96e-13 | 29 | 160 | 9 | CID000000414 |
| Drug | tolcapone | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 4.20e-13 | 30 | 160 | 9 | CID004659569 |
| Drug | paricalcitol | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 4.20e-13 | 30 | 160 | 9 | CID005281104 |
| Drug | 4'-HPPH | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 5.88e-13 | 31 | 160 | 9 | CID000017732 |
| Drug | 4-ethylphenol | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 5.88e-13 | 31 | 160 | 9 | CID000031242 |
| Drug | Muracein C | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 8.14e-13 | 32 | 160 | 9 | CID003086323 |
| Drug | R(-)-Denopamine | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.11e-12 | 33 | 160 | 9 | CID000003818 |
| Drug | norbuprenorphine | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.11e-12 | 33 | 160 | 9 | CID000114976 |
| Drug | AC1Q6OQG | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.11e-12 | 33 | 160 | 9 | CID000009686 |
| Drug | 6-methylsalicylic acid | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.11e-12 | 33 | 160 | 9 | CID000011279 |
| Drug | BP-3,6-quinol | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.11e-12 | 33 | 160 | 9 | CID000119292 |
| Drug | geniposide | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.11e-12 | 33 | 160 | 9 | CID000107848 |
| Drug | campestrol | EVC2 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.44e-12 | 49 | 160 | 10 | CID000010134 |
| Drug | estragole | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.50e-12 | 34 | 160 | 9 | CID000008815 |
| Drug | AC1NOWCJ | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 2.01e-12 | 35 | 160 | 9 | CID005120112 |
| Drug | 3-[(3S,5R,10S,13R,14S,17R)-3-[(2S,4R,5R,6S)-4,5-dihydroxy-6-methyloxan-2-yl]oxy-14-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 2.01e-12 | 35 | 160 | 9 | CID010436171 |
| Drug | estrone-3-glucuronide | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 2.01e-12 | 35 | 160 | 9 | CID000115255 |
| Drug | nitrosamine | ABCC1 SPR UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 2.21e-12 | 70 | 160 | 11 | CID000037183 |
| Drug | muraglitazar | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 2.67e-12 | 36 | 160 | 9 | CID000206044 |
| Drug | glucoraphanin | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 2.67e-12 | 36 | 160 | 9 | CID000656556 |
| Drug | AC1L9DGV | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 2.67e-12 | 36 | 160 | 9 | CID000417381 |
| Drug | bevirimat | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 2.67e-12 | 36 | 160 | 9 | CID000457928 |
| Drug | 8-prenylnaringenin | ABCC1 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 2.72e-12 | 52 | 160 | 10 | CID000480764 |
| Drug | AC1NQGK1 | ABCC1 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 2.72e-12 | 52 | 160 | 10 | CID005195977 |
| Drug | acotiamide | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 3.50e-12 | 37 | 160 | 9 | CID005282338 |
| Disease | X-11442 measurement | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 2.41e-21 | 9 | 155 | 9 | EFO_0021236 |
| Disease | X-11441 measurement | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 2.41e-21 | 9 | 155 | 9 | EFO_0021235 |
| Disease | circulating cell free DNA measurement | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 2.41e-21 | 9 | 155 | 9 | EFO_0004739 |
| Disease | bilirubin measurement, response to xenobiotic stimulus | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 2.41e-21 | 9 | 155 | 9 | EFO_0004570, GO_0009410 |
| Disease | bilirubin measurement, response to tenofovir | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 2.40e-20 | 10 | 155 | 9 | EFO_0004570, EFO_0009279 |
| Disease | UDP-glucuronosyltransferase 1-6 measurement | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 2.40e-20 | 10 | 155 | 9 | EFO_0802185 |
| Disease | histidine betaine (hercynine) measurement | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.31e-19 | 11 | 155 | 9 | EFO_0800972 |
| Disease | X-21796 measurement | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.31e-19 | 11 | 155 | 9 | EFO_0800825 |
| Disease | insomnia, bilirubin measurement | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.31e-19 | 11 | 155 | 9 | EFO_0004570, EFO_0004698 |
| Disease | aldosterone measurement | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.31e-19 | 11 | 155 | 9 | EFO_0010219 |
| Disease | X-11793--oxidized bilirubin measurement | 4.83e-19 | 8 | 155 | 8 | EFO_0021260 | |
| Disease | Succinimide measurement | 4.83e-19 | 8 | 155 | 8 | EFO_0022118 | |
| Disease | X-11530 measurement | 4.83e-19 | 8 | 155 | 8 | EFO_0021249 | |
| Disease | sulfate of piperine metabolite C16H19NO3 (2) measurement | 4.83e-19 | 8 | 155 | 8 | EFO_0801034 | |
| Disease | cholelithiasis, bilirubin measurement | 4.83e-19 | 8 | 155 | 8 | EFO_0004570, EFO_0004799 | |
| Disease | X-11522 measurement | 4.83e-19 | 8 | 155 | 8 | EFO_0800696 | |
| Disease | X-10458 measurement | 4.83e-19 | 8 | 155 | 8 | EFO_0800692 | |
| Disease | X-24849 measurement | 4.83e-19 | 8 | 155 | 8 | EFO_0800909 | |
| Disease | membrane-associated progesterone receptor component 1 measurement | 4.83e-19 | 8 | 155 | 8 | EFO_0802740 | |
| Disease | X-16946 measurement | 4.83e-19 | 8 | 155 | 8 | EFO_0800766 | |
| Disease | biliverdin measurement | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 5.22e-19 | 12 | 155 | 9 | EFO_0021033 |
| Disease | sulfate of piperine metabolite C18H21NO3 (3) measurement | 4.33e-18 | 9 | 155 | 8 | EFO_0801037 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (1) measurement | 4.33e-18 | 9 | 155 | 8 | EFO_0801036 | |
| Disease | X-11880 measurement | 4.33e-18 | 9 | 155 | 8 | EFO_0800698 | |
| Disease | protein-tyrosine kinase 6 measurement | 4.33e-18 | 9 | 155 | 8 | EFO_0020691 | |
| Disease | testis-specific chromodomain protein Y 1 measurement | 4.33e-18 | 9 | 155 | 8 | EFO_0802127 | |
| Disease | X-21448 measurement | 2.15e-17 | 10 | 155 | 8 | EFO_0800816 | |
| Disease | X-23974 measurement | 2.15e-17 | 10 | 155 | 8 | EFO_0800867 | |
| Disease | low density lipoprotein cholesterol measurement, body fat percentage | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 5.65e-17 | 17 | 155 | 9 | EFO_0004611, EFO_0007800 |
| Disease | xanthurenate measurement | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 GRM7 UGT1A4 UGT1A1 UGT1A3 | 2.19e-16 | 29 | 155 | 10 | EFO_0010551 |
| Disease | p-cresol glucuronide measurement | 2.35e-16 | 12 | 155 | 8 | EFO_0800079 | |
| Disease | retinol dehydrogenase 16 measurement | 6.08e-16 | 13 | 155 | 8 | EFO_0802007 | |
| Disease | X-21441 measurement | 1.13e-14 | 17 | 155 | 8 | EFO_0800814 | |
| Disease | angiopoietin-related protein 1 measurement | 2.02e-14 | 18 | 155 | 8 | EFO_0801382 | |
| Disease | pregnenetriol sulfate measurement | 3.12e-14 | 11 | 155 | 7 | EFO_0800586 | |
| Disease | plasma N-desmethylclozapine measurement | 3.12e-14 | 11 | 155 | 7 | EFO_0600039 | |
| Disease | response to dolutegravir | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 3.14e-14 | 30 | 155 | 9 | EFO_0600017 |
| Disease | tissue factor measurement | 9.28e-14 | 21 | 155 | 8 | EFO_0010623 | |
| Disease | pregnenetriol disulfate measurement | 1.61e-13 | 13 | 155 | 7 | EFO_0800587 | |
| Disease | serum N-desmethylclozapine measurement | 5.29e-13 | 8 | 155 | 6 | EFO_0600043 | |
| Disease | plasma clozapine measurement | 5.29e-13 | 8 | 155 | 6 | EFO_0600038 | |
| Disease | N-acetyl-4-chlorophenylalanine measurement | 3.75e-12 | 5 | 155 | 5 | EFO_0801060 | |
| Disease | nuclear receptor subfamily 1 group D member 2 measurement | 3.75e-12 | 5 | 155 | 5 | EFO_0801853 | |
| Disease | urate measurement, spine bone mineral density | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 2.06e-11 | 58 | 155 | 9 | EFO_0004531, EFO_0007701 |
| Disease | X-21339 measurement | 7.81e-11 | 7 | 155 | 5 | EFO_0800808 | |
| Disease | gallstones | UBR1 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 2.97e-10 | 108 | 155 | 10 | EFO_0004210 |
| Disease | thyroxine measurement | UGT1A10 UGT1A8 ZGRF1 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A3 | 5.69e-10 | 83 | 155 | 9 | EFO_0005130 |
| Disease | hormone measurement | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 RYR2 UGT1A4 UGT1A3 | 6.34e-10 | 84 | 155 | 9 | EFO_0004730 |
| Disease | vitamin D deficiency | 8.69e-10 | 37 | 155 | 7 | EFO_0003762 | |
| Disease | cholelithiasis | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 9.67e-10 | 88 | 155 | 9 | EFO_0004799 |
| Disease | metabolite measurement | PDXDC1 ABCC1 PECR UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 LIPC ASAH1 DMD ASB2 DNMBP SEC14L2 | 1.05e-09 | 560 | 155 | 18 | EFO_0004725 |
| Disease | 5-hydroxyindole sulfate measurement | 3.65e-09 | 5 | 155 | 4 | EFO_0800085 | |
| Disease | 3-carboxy-4-methyl-5-pentyl-2-furanpropionate (3-CMPFP) measurement | 1.09e-08 | 6 | 155 | 4 | EFO_0800566 | |
| Disease | indole-3-carboxylate measurement | 1.42e-07 | 3 | 155 | 3 | EFO_0800043 | |
| Disease | blood 4-oxo-retinoic acid measurement | 1.42e-07 | 3 | 155 | 3 | EFO_0022216 | |
| Disease | vitamin D measurement, COVID-19 | 2.21e-07 | 49 | 155 | 6 | EFO_0004631, MONDO_0100096 | |
| Disease | neuroblastoma, cutaneous melanoma | 3.34e-07 | 28 | 155 | 5 | EFO_0000389, EFO_0000621 | |
| Disease | X-24588 measurement | 5.05e-07 | 13 | 155 | 4 | EFO_0800898 | |
| Disease | serum metabolite measurement | PDXDC1 ABCC1 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 GRM7 CBS ATL1 UGT1A4 UGT1A1 UGT1A3 PARP4 GTF2H1 LIPC DNAH17 SNTB1 | 6.00e-07 | 945 | 155 | 19 | EFO_0005653 |
| Disease | non-high density lipoprotein cholesterol measurement | COL4A2 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 DENND4C UGT1A4 UGT1A1 UGT1A3 RAB10 THADA LIPC FAR2 BRCA2 | 1.21e-06 | 713 | 155 | 16 | EFO_0005689 |
| Disease | Adult only | 2.81e-06 | 6 | 155 | 3 | C3842001 | |
| Disease | bilirubin measurement | UBR1 UGT1A10 UGT1A8 UGT1A7 UGT1A6 INPP5D UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 DNMBP | 4.14e-06 | 442 | 155 | 12 | EFO_0004570 |
| Disease | Intellectual Disability | PECR KDM5A SPR ASH1L ATL1 PARP1 BRCA1 NRXN2 ASAH1 SCN8A ZBTB40 ALDH4A1 | 4.65e-06 | 447 | 155 | 12 | C3714756 |
| Disease | free androgen index | COL4A2 UGT1A10 UGT1A8 UGT1A7 UGT1A6 SMCHD1 UGT1A5 UGT1A9 UGT1A4 THADA DNMBP | 4.98e-06 | 374 | 155 | 11 | EFO_0007005 |
| Disease | apolipoprotein B measurement | COL4A2 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A3 RAB10 THADA LIPC BRCA2 RBM47 | 1.15e-05 | 663 | 155 | 14 | EFO_0004615 |
| Disease | vitamin D measurement | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 ASH1L UGT1A9 UGT1A4 LIPC ZNF808 | 1.22e-05 | 336 | 155 | 10 | EFO_0004631 |
| Disease | indoleacetate measurement | 1.66e-05 | 10 | 155 | 3 | EFO_0021015 | |
| Disease | Fanconi anemia (is_implicated_in) | 1.66e-05 | 10 | 155 | 3 | DOID:13636 (is_implicated_in) | |
| Disease | late-onset Alzheimers disease | 2.56e-05 | 292 | 155 | 9 | EFO_1001870 | |
| Disease | serum gamma-glutamyl transferase measurement | UBR1 UGT1A10 UGT1A8 UGT1A7 UGT1A6 ASH1L UGT1A9 ARHGAP35 RYR2 UBE4A THADA TENM4 NUAK1 AHNAK KMT2A DNMBP | 2.71e-05 | 914 | 155 | 16 | EFO_0004532 |
| Disease | ductal carcinoma in situ (biomarker_via_orthology) | 2.74e-05 | 2 | 155 | 2 | DOID:0060074 (biomarker_via_orthology) | |
| Disease | Hereditary site-specific ovarian cancer syndrome | 2.74e-05 | 2 | 155 | 2 | C4749652 | |
| Disease | esophagus squamous cell carcinoma (is_implicated_in) | 9.23e-05 | 45 | 155 | 4 | DOID:3748 (is_implicated_in) | |
| Disease | type 2 diabetes mellitus (biomarker_via_orthology) | 1.31e-04 | 147 | 155 | 6 | DOID:9352 (biomarker_via_orthology) | |
| Disease | Hereditary breast ovarian cancer syndrome | 1.63e-04 | 4 | 155 | 2 | cv:C0677776 | |
| Disease | complex cortical dysplasia with other brain malformations (is_implicated_in) | 1.63e-04 | 4 | 155 | 2 | DOID:0090131 (is_implicated_in) | |
| Disease | prostate cancer (is_marker_for) | 1.81e-04 | 156 | 155 | 6 | DOID:10283 (is_marker_for) | |
| Disease | ovarian cancer (is_implicated_in) | 2.18e-04 | 56 | 155 | 4 | DOID:2394 (is_implicated_in) | |
| Disease | Bipolar Disorder | 2.26e-04 | 477 | 155 | 10 | C0005586 | |
| Disease | hereditary breast ovarian cancer syndrome (is_implicated_in) | 2.71e-04 | 5 | 155 | 2 | DOID:5683 (is_implicated_in) | |
| Disease | Fanconi Anemia | 3.00e-04 | 25 | 155 | 3 | C0015625 | |
| Disease | breast cancer (implicated_via_orthology) | 3.00e-04 | 25 | 155 | 3 | DOID:1612 (implicated_via_orthology) | |
| Disease | Acute monocytic leukemia | 3.38e-04 | 26 | 155 | 3 | C0023465 | |
| Disease | kidney disease (is_implicated_in) | 4.06e-04 | 6 | 155 | 2 | DOID:557 (is_implicated_in) | |
| Disease | level of Phosphatidylcholine (18:1_20:3) in blood serum | 4.06e-04 | 6 | 155 | 2 | OBA_2045103 | |
| Disease | 1-dihomo-linolenoyl-GPE (20:3n3 or 6) measurement | 4.06e-04 | 6 | 155 | 2 | EFO_0800358 | |
| Disease | squamous cell carcinoma | 4.34e-04 | 67 | 155 | 4 | EFO_0000707 | |
| Disease | Miller Dieker syndrome | 4.70e-04 | 29 | 155 | 3 | C0265219 | |
| Disease | Neoplasm of uncertain or unknown behavior of ovary | 4.70e-04 | 29 | 155 | 3 | C0496920 | |
| Disease | Ovarian Carcinoma | 5.20e-04 | 30 | 155 | 3 | C0029925 | |
| Disease | Breast Cancer, Familial | 5.20e-04 | 30 | 155 | 3 | C0346153 | |
| Disease | metabolite measurement, diet measurement | 5.41e-04 | 71 | 155 | 4 | EFO_0004725, EFO_0008111 | |
| Disease | response to platinum based chemotherapy, response to antineoplastic agent | 5.66e-04 | 7 | 155 | 2 | EFO_0004647, GO_0097327 | |
| Disease | Arima syndrome | 5.66e-04 | 7 | 155 | 2 | C1855675 | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 5.90e-04 | 128 | 155 | 5 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 5.90e-04 | 128 | 155 | 5 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 5.90e-04 | 128 | 155 | 5 | C1266044 | |
| Disease | Papillary Renal Cell Carcinoma | 5.90e-04 | 128 | 155 | 5 | C1306837 | |
| Disease | Renal Cell Carcinoma | 5.90e-04 | 128 | 155 | 5 | C0007134 | |
| Disease | Abnormality of radial ray | 6.91e-04 | 33 | 155 | 3 | C4228778 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AAVADKKKGLMGPLT | 216 | O75528 | |
| PEKKAMAIADALGKI | 316 | P35503 | |
| LAVLMKGKPRVQDGK | 411 | Q9NRG9 | |
| ADMLGSLGPKEAKKA | 81 | Q92888 | |
| NKDIGKKLMSCPLAG | 401 | Q9NR48 | |
| DVVKNPMDLGTIKEK | 311 | Q58F21 | |
| KNGKKASEPKEVMGE | 81 | Q9Y4W6 | |
| GKEKALMKAVATVGP | 231 | O60911 | |
| LKTMIKEGKNLAEPN | 121 | Q96Q27 | |
| KIMEIKLIKGPKGLG | 316 | Q12959 | |
| AGSLKMEPKNKGLKQ | 311 | Q49A92 | |
| PVKDGLLKANCGMKV | 721 | Q9BXX3 | |
| VTKGGIMLPEKSQGK | 26 | P61604 | |
| VILPGMKDIKGEKGD | 981 | P08572 | |
| QKALKDLKGRMEAIP | 51 | P30038 | |
| DVDLDLKGPKMKGNV | 1071 | Q09666 | |
| LNLKGPKVKGDMDVS | 2191 | Q09666 | |
| IDLNLKGPKVKGDMD | 3096 | Q09666 | |
| LNLKGPKMKGEVDVS | 3226 | Q09666 | |
| FDLNLKGPKMKGDVV | 3676 | Q09666 | |
| NLKGPKVKGDMDVSL | 3881 | Q09666 | |
| KVKGDMDVSLPKVEG | 3886 | Q09666 | |
| LNLKGPKMKGDVDVS | 4136 | Q09666 | |
| MSDIDLNLKGPKIKG | 4521 | Q09666 | |
| LNLKGPKIKGDMDIS | 4526 | Q09666 | |
| NLKGPKVKGDMDISL | 4601 | Q09666 | |
| KVKGDMDISLPKVEG | 4606 | Q09666 | |
| LVGVIKKKDPMGSQN | 1311 | Q6XZF7 | |
| MEEEGKKGKKPGIVS | 1 | Q9BSQ5 | |
| GKIMQVVDEKLPGLL | 91 | Q13510 | |
| KIQSIALKEKGQGPM | 891 | P11532 | |
| GTGPKNITKKMIDKL | 1541 | Q5T5Y3 | |
| AKVQVLKPLMGLSEK | 251 | Q7L4S7 | |
| AGAKKEIAMIKVAAP | 701 | Q709F0 | |
| SDNNMVKPLGLLGKK | 66 | Q8TD07 | |
| MDDKRVVPKGKGEQI | 126 | P61026 | |
| GGIPKMKKREEILEE | 156 | A0AV96 | |
| KRMKLTLKGGAAVDP | 521 | P09874 | |
| ESKKMPVAGGKANKD | 46 | Q9UGN5 | |
| ATGPKMLVDLLAKNK | 76 | Q8NH69 | |
| LKEDMAGIPKAKQRL | 446 | Q96K12 | |
| SSGGIPKNMEKLVKL | 1186 | Q9NVI1 | |
| MLAGPDLKEDLQKLK | 91 | Q9NXN4 | |
| NASGPIKEKMGIFKI | 811 | Q9NRZ9 | |
| MSKKGRNKGEKPEAL | 1 | Q96AA8 | |
| AVKKKPMASLDGKGD | 1006 | Q96JA1 | |
| EKPEASMEVKGQKLI | 881 | P19823 | |
| KLQKLKGGEEGPVLM | 881 | Q9UBC5 | |
| EAIPMLVAGLKGLKV | 591 | O95714 | |
| IPKIIDGNVNGMKRK | 1186 | Q2LD37 | |
| MKGPKGLEELVKQKD | 491 | O75369 | |
| AGRKPLKSGMKELAV | 176 | P18065 | |
| KKPDDGKMKGLAFIQ | 151 | Q04760 | |
| LNAFKMLDPDGKGKI | 106 | Q02045 | |
| PTLAEMGKNLKEAVK | 11 | Q6P996 | |
| PTLAEMGKNLKEAVK | 11 | Q6P474 | |
| PKGAGDLSVVKKMKE | 281 | Q9BY49 | |
| SRLAKEGDPKMKLQG | 466 | Q9P2S2 | |
| KGELKPEAAKMLLQN | 551 | Q86UK5 | |
| EKMQKIPITLGKGIA | 381 | P11150 | |
| KTKDNPGSIGKVKVM | 361 | Q9ULI4 | |
| LPQKAGGFLMKKELN | 181 | P00558 | |
| KGTMPKEVNLGLLAK | 331 | Q9UKK3 | |
| PKVVGLAMGTKDKED | 246 | P29375 | |
| KDLNPGVKKMSLGQL | 6 | Q9NZU5 | |
| MLAKKIIIKDGGTPQ | 16 | Q96MC6 | |
| MVKLAKAGKNQGDPK | 1 | P19338 | |
| GLFNMGLKEVKKEPG | 256 | Q8IZL2 | |
| LLKKEGKDKNGMPVE | 431 | Q13772 | |
| GQKKDKLGPETFLAM | 76 | P10696 | |
| KGIMENPIVKSLAKA | 26 | Q9NZW5 | |
| LQLMEGKEPATGAKK | 666 | P38398 | |
| DGKQGKVIMPLGSKL | 1376 | Q8NFC6 | |
| LINKPDGKKVAVLLM | 131 | Q8WXF7 | |
| GKEQASPKNVKMEIG | 2181 | P51587 | |
| NMDLAKSGIKILVPK | 186 | Q9Y232 | |
| AMLQGVLEKPLEKKS | 2491 | Q9UFH2 | |
| QAIKEMQKDPDVKGG | 656 | O15078 | |
| GVLMKVGEANPKLQK | 146 | P00915 | |
| LSTGKVGMLKNLKEP | 766 | Q6MZW2 | |
| MDDSKVVGGKVKKPG | 1 | O60519 | |
| EPGNKMKQAKSVGDL | 256 | Q9UBX1 | |
| VEEMKESKLPGDKGL | 106 | P27824 | |
| DTPMVRINKIGKKFG | 86 | P35520 | |
| GPKIDVLKSGMKQAA | 1356 | Q5VZ89 | |
| PKMVKFLLEKGADVN | 171 | Q92527 | |
| IQKETKQGALCGMKP | 81 | Q9H0H9 | |
| MAGPGIKRLKLDTKV | 286 | Q6GMR7 | |
| VCPEMEQAGGKKLLK | 436 | Q14831 | |
| DGGQPEIKKANSMVK | 1741 | Q03164 | |
| LDIIKQEGKMQEGKG | 3701 | Q8NDH2 | |
| KVIPELKGKLTGMAF | 291 | O14556 | |
| KEAVKAAAKGPMAGI | 331 | O14556 | |
| ALKKVLMENEKEGFP | 46 | P50750 | |
| LMIKQGLLDKHGKPT | 391 | O60832 | |
| PDKASEEKMKQLGAG | 386 | O76054 | |
| GAKKIKVAELLANMP | 4321 | Q92736 | |
| PEGKAEEVMKVKLSG | 261 | Q96RY7 | |
| KGKKGEQMNSAVLPE | 246 | P43246 | |
| KPVGGTKMDKDILER | 476 | Q9C0B2 | |
| LGEGKMENPKGESLK | 341 | Q8WZA9 | |
| IFENVIGPKGMLKNK | 806 | P33527 | |
| VKKGVPMAKEGNLEL | 91 | P82673 | |
| DGGILCEIVKLKPKM | 201 | P52788 | |
| SIKGGKENKMPILIS | 126 | Q13884 | |
| KQIVPLLEKADKNGM | 56 | Q6YHU6 | |
| KMVEKDQDGGRKLTP | 111 | P39019 | |
| EILNKKGEAMQKLPG | 721 | A6NHR9 | |
| KLEKSKPGLGIDQMV | 916 | Q4G0N8 | |
| KPGLGIDQMVESKEK | 921 | Q4G0N8 | |
| IAKTGMDPQKVLLAK | 551 | Q7LBE3 | |
| DKETGVKKLPGVMLF | 321 | Q86YW0 | |
| AGGSKEKIDMKKLLP | 1261 | Q96Q15 | |
| PQKMQLKVDVESGKL | 311 | Q92835 | |
| GKKNKTPVQLDLGDM | 481 | Q93073 | |
| GPDISKMGSINKNKV | 3106 | O75592 | |
| LQADTEAKMKGLAKP | 341 | O60285 | |
| LKKVKFIPGSALNGM | 496 | Q9NSE4 | |
| KPSKEKMGVIQDVLG | 511 | Q9NRY4 | |
| KLKVAGMLAVGKEVN | 486 | Q08188 | |
| KNSPMEDLGAKGAKE | 461 | Q66K14 | |
| SEMEKIPEIGKFGEK | 16 | Q5QGZ9 | |
| GKRKKGLEMDPIDCT | 171 | O75153 | |
| PEVVALGAAEKKVKM | 291 | Q15025 | |
| SEMCAVPGGLAKVKK | 71 | A4UGR9 | |
| AAGMSAKERPKGKVI | 46 | Q7Z2D5 | |
| AEPANAVKGAGKEMK | 276 | Q63HN8 | |
| EKGLKTMVSLGVKNP | 251 | P32780 | |
| KKDKDGKSPLDGAMV | 526 | Q8N0X7 | |
| KMKDQLLPEKGCGLA | 31 | Q8TF68 | |
| PVGGLGKLKMIIAKN | 816 | Q05086 | |
| GKLKMIIAKNGPDTE | 821 | Q05086 | |
| KIEIKLSDIPEGKNM | 151 | P47985 | |
| IPEKKAMAIADALGK | 311 | Q9HAW8 | |
| GKKPRVMAGTLKLED | 506 | O00541 | |
| PDMRKGLQELKAKGK | 216 | P35270 | |
| CKQELPKLMDLHGKG | 271 | Q92670 | |
| IMVLGDINTKPKKEN | 1086 | P55011 | |
| EKKAMAIADALGKIP | 316 | P22309 | |
| GAGLVMKVKQEKPER | 11 | Q96BV0 | |
| APLAGKGKQLEEKMV | 136 | Q9UHA3 | |
| PEKKAMAIADALGKI | 316 | P35504 | |
| KLKGIPQLEGQKDMI | 961 | Q8IWV7 | |
| AAQKRKGKESGMALP | 6 | Q8N4W9 | |
| VTGDKKKETQPGKMQ | 201 | Q9UKX3 | |
| VALNMLGELDKKKEP | 1616 | Q5SRE5 | |
| DNMGRVVKKELKVGP | 2171 | Q6N022 | |
| VEIKKKGPGSLLVSM | 671 | Q9UQD0 | |
| PGISEDLKKVKDRMG | 226 | Q9NPH0 | |
| KVAQAKLKEIGPDDM | 866 | Q96RU2 | |
| IPEKKAMAIADALGK | 311 | O60656 | |
| AGNMLVKKIQPLAKA | 446 | P22102 | |
| GKIILEEKNKVSMAP | 206 | Q16222 | |
| EMQPKLKQVFGKGLI | 111 | Q7Z4N2 | |
| GELPMKEKEALGKLL | 456 | O15090 | |
| KLVMVKKEGPNKGRL | 1356 | Q86YA3 | |
| AAQKRKEKEPGMALP | 6 | A6NHJ4 | |
| KKAEPADLQGMLLKN | 851 | Q2M1K9 | |
| QHLVGPKMGALKVKD | 886 | Q14139 | |
| KKAMAIADALGKIPQ | 316 | P19224 | |
| KMNLTKLGKEPLVEA | 911 | Q8IWB9 | |
| PARQKVMVKGGTLKD | 41 | P54578 | |
| VLKQDMPLVGAEKRK | 56 | Q6NT04 | |
| ADPKQGMSLDIVLKK | 106 | Q9NRD5 | |
| KKVIFLEPGNVTMGK | 1371 | Q6ZQQ6 | |
| LEPGNVTMGKEISKK | 1376 | Q6ZQQ6 | |
| MPGKVIDIKVVAGAK | 1116 | P11498 | |
| IPEKKAMAIADALGK | 311 | Q9HAW7 | |
| IMKPCGKAQGKGIFL | 136 | O95922 | |
| IKGPQKEMIVKCFEG | 271 | Q9NUA8 | |
| IPEKKAMAIADALGK | 311 | Q9HAW9 | |
| GDNPEKKKLQEQLMG | 101 | Q9UN37 | |
| PEKKAMAIADALGKI | 316 | P22310 | |
| LEIAEKKLLGPLGMK | 1401 | P35573 | |
| IDPIAKAKMVALKGI | 3421 | O14686 | |
| VVSVLKDGKPEMNKQ | 856 | Q9UM54 | |
| KGKMVGFQSLQDDPK | 1096 | P20929 |